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Summary 
This thesis consists of three prospective studies, examining whether leisure time 
physical activity may compensate for the adverse association between diabetes and risk 
of death from cardiovascular disease and risk of acute myocardial infarction (AMI). We 
have used data from the HUNT Study, linked with the Cause of Death Registry as well 
as hospital admissions due to acute myocardial infarction at the two hospitals in Nord-
Trøndelag County. 
 Diabetes was associated with almost threefold higher risk of death from 
cardiovascular disease among the physically inactive. People with diabetes who 
reported ≥ 3 hours of light physical activity had similar risk as inactive people without 
diabetes. We also found that the favourable effect of physical activity were largest 
among those with most severe diabetes, measured as medical treatment status. Finally, 
we found an increased risk of first acute myocardial infarction among people with 
diabetes, and that this excess risk was cancelled out among those who reported a high 
physical activity level. Moreover, a normal body weight was associated with lower risk 
of first AMI, especially when combined with a moderate or high level of physical 
activity. 
 Our results suggests that the favourable effect of physical activity should be 
within reach for most people with diabetes and should be more strongly encouraged as a 
therapeutic measure additional to medical treatment.  
  
 
 
  
 
 
Norwegian summary 
Denne avhandlingen består av tre prospektive studier som undersøker hvorvidt fysisk 
aktivitet kan kompensere for den uheldige sammenhengen mellom diabetes og risiko for 
kardiovaskulær død og risiko for hjerteinfarkt. Vi har benyttet data fra 
Helseundersøkelsen i Nord-Trøndelag koblet til Dødsårsaksregisteret, samt informasjon 
om sykehusinnleggelser grunnet hjerteinfarkt ved de to sykehusene i Nord-Trøndelag.   
Diabetes var assosiert med nesten tre ganger så høy risiko for å dø av 
kardiovaskulær sykdom hos de fysisk inaktive. Personer med diabetes som rapporterte ≥ 
3 timer med lett fysisk aktivitet per uke, hadde tilsvarende risiko som inaktive personer 
uten diabetes. Videre fant vi at den gunstige effekten av fysisk aktivitet var størst for de 
med alvorligst grad av diabetes, målt som medikamentell behandling. Vi fant også en 
økt risiko for hjerteinfarkt blant personer med diabetes, og at denne forhøyete risikoen 
ble kansellert blant de som rapporterte et høyt fysisk aktivitetsnivå. En normal 
kroppsvekt var også assosiert med lavere risiko for hjerteinfarkt, særlig i kombinasjon 
med fysisk aktivitet. 
 Våre resultater tyder på at den gunstige effekten av fysisk aktivitet er innen 
rekkevidde for de fleste med diabetes og i enda større grad bør vektlegges som et ledd i 
behandlingen av personer med diabetes, i tillegg til medisinering.   
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1 Introduction 
The incidence of diabetes has increased during the past decades (1-3). Worldwide, it has 
been estimated that 347 million people had diabetes in 2011 (4) and that the prevalence 
will increase to 439 million by 2030 (5). In Norway approximately 90,000–120,000 
individuals were diagnosed with diabetes in 2004 and it is expected that almost as many 
have undiagnosed diabetes (6).  
Diabetes increases the risk of cardiovascular disease (7), whereas leisure time 
physical activity is found to reduce the risk of cardiovascular disease in both people 
with and without diabetes (8-11). However, whether physical activity could reduce the 
excess risk of cardiovascular disease associated with diabetes is not known.  
Increased knowledge of effective means for primary prevention of 
cardiovascular disease among people with diabetes is therefore important (12).  
 
1.1 Pathology of diabetes 
Diabetes is a chronic metabolic disease characterized by hyperglycemia that is caused 
by either insufficient insulin production, insufficient insulin action, or both (13). The 
disease is diagnosed by demonstrating any of the following glucose criteria according to 
the World Health Organization (WHO) and the International Diabetes Federation (IDF): 
a fasting plasma glucose level at or above 7.0 mmol/L, a plasma glucose level at or 
above 11.1 mmol/L two hours after a 75 g oral glucose load in a glucose tolerance test, 
or symptoms of hyperglycemia and a casual plasma glucose level at or above 11.1 
mmol/L (14).  
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Type 1 diabetes (previously known as insulin dependent diabetes or juvenile 
diabetes), accounts for approximately 5–10 % of the diabetes cases (15), and occurs 
most commonly in childhood and early adulthood (16; 17). The pathophysiology of the 
disease is characterized by the autoimmune destruction of the insulin-producing beta 
cells of the islets of Langerhans in the pancreas, leading to insulin deficiency (18). 
Although, some individuals may retain sufficient beta cell functioning for years, 
individuals with type 1 diabetes will usually be dependent on exogenous insulin to 
survive (19). The reason why people develop type 1 is not entirely understood, but it is 
believed that both genetic factors and environmental triggers are involved (13; 20-22).  
Type 2 diabetes (previously known as noninsulin-dependent diabetes or adult 
onset diabetes) is responsible for about 90–95 % of the cases (15), and occurs most 
commonly in middle-aged persons (16). The pathophysiology of the disease is 
characterized by insulin resistance and usually a relative insulin deficiency, in contrast 
with the more absolute insulin deficiency in type 1 diabetes (23; 24). The disease 
develops gradually, beginning with insulin resistance; a condition in which the muscle, 
fat and liver cells have a diminished ability to respond to the normal actions of insulin 
(25). Subsequently, the beta cells increase the production of insulin to overcome the 
insulin resistance. Over time, the beta cells are unable to produce the required amount of 
insulin to overcome the insulin resistance, resulting in hyperglycemia (26). Chronic 
hyperglycemia increases inflammatory chemicals which impairs and possibly destroys 
beta cells, leading to a vicious cycle where more inflammation results in more insulin 
resistance and vice versa (27). This process occurs gradually and with few initial 
symptoms. Therefore, type 2 diabetes is often undiagnosed for several years, and for 
some it may remain undiagnosed throughout life (15). The precise cause of type 2 
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diabetes is unknown, but it is believed that it is caused by a combination of genetic 
predispositions, obesity, physical inactivity, and increasing age (13; 20; 28-30). 
Research also indicates that the risk of diabetes is increased in people with hypertension 
and dyslipidemia (31).  
People with diabetes are advised to achieve adequate glycemic control. 
According to the recommendations by The American Diabetes Association, this 
corresponds to a glycated hemoglobin level (HbA1C) < 7 % (19). HbA1C reflects the 
average blood glucose over the preceding two to three months. Some individuals may 
achieve this goal with weight reduction, physical activity, and/or glucose lowering 
agents, while others require exogenous insulin in addition (32). However, glycemic 
control usually worsens over time due to a progressive loss in beta cells, so a gradual 
progression to more intensive treatment is common (33; 34).  
For both types of diabetes, elevated levels of plasma glucose is associated with 
microvascular complications (diabetic nephropathy, neuropathy, and retinopathy) and 
macrovascular complications (coronary artery disease, peripheral arterial disease, and 
stroke) (35). Therefore, glycemic control is important to avoid or delay complications 
associated with the disease (35-37). Because the onset of diabetes usually occurs several 
years prior to the clinical diagnosis, micro- and macrovascular complications are often 
present at the time when diabetes is diagnosed (38-40).   
 
1.2 Diabetes and cardiovascular disease 
Nearly 80% of people with diabetes die from cardiovascular disease (41). This 
represents a substantial burden to the individuals with diabetes and their families, as 
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well as to the society (42). Several prospective cohort studies have found a 2-4 fold 
higher risk of death from cardiovascular disease in people with diabetes, compared to 
people without diabetes (43-47). Previous studies also indicate that diabetes might be 
more detrimental for women than men (48-50). In people with diabetes, studies have 
reported increased cardiovascular mortality associated with hyperglycaemi, 
hypertension , dyslipidaemia and overweight (9; 44; 51; 52). These modifiable risk 
factors tend to accelerate the progression of atherosclerosis, and should be targets for 
lowering the risk of cardiovascular disease in people with diabetes (53). A higher risk of 
death from cardiovascular disease is also found in those treated with oral hypoglycemic 
drugs or insulin (54; 55) and in those with longer duration of diabetes (56-59). Longer 
duration of diabetes implies a longer exposure to hyperglycemia and is also found to be 
associated with increased prevalence of classical cardiovascular risk factors (e.g. 
hypertension and dyslipidaemia) (60). The combination of insulin treatment and longer 
duration of diabetes has been associated with a particular high risk of death from 
cardiovascular disease (61). These findings suggest that diabetes treatment and duration 
are important markers for diabetes severity.  
Although a broad-based treatment of the mentioned risk factors may reduce the 
risk of cardiovascular complications, the knowledge of effective means for primary 
prevention of myocardial infarction and cardiovascular death among people with 
diabetes is still sparse (41). 
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1.3 Diabetes, cardiovascular disease and the role of physical activity 
Regular physical activity in persons with diabetes may improve glycaemic control and 
several cardiovascular risk factors (62-65). Previous studies have shown that increasing 
levels of physical activity are associated with lower risk of cardiovascular death in both 
the general population (10; 11) and among people with diabetes (8; 9). 
According to international recommendations (66), the general population is 
advised to perform at least 150 minutes of moderate-intensity aerobic physical activity, 
or at least 75 minutes of vigorous intensity aerobic physical activity per week. Moderate 
intensity should noticeably accelerate the heart rate such as during a brisk walk, whereas 
vigorous intensity should substantially increase the heart rate and cause rapid breathing. 
Different combinations of moderate and vigorous intensity physical activity can be 
performed to meet the recommendations. For additional benefit, people are advised to 
increase moderate intensity activity to 300 minutes, or their vigorous activity to 150 
minutes per week.  Additionally, activities that maintain or increase muscular strength 
and endurance in the major muscle groups should be performed two days each week. 
These recommendations have been adopted by the Norwegian guidelines, which was 
recently updated to incorporate advise on reducing sedentary time (67). Current 
guidelines for people with diabetes are equivalent to those of the general population, but 
highlight the dose-response relation between physical activity and health and suggest 
that a larger amount of physical activity (7 hours of moderate or vigorous aerobic 
activity) may be helpful (41; 68-70). Because physical activity can result in acute 
improvements in systemic insulin action lasting from 2 to 72 hours, people with 
diabetes are advised to spread out their physical activity over at least three days during 
the week.  
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Previous studies have shown that physical activity may compensate for the 
adverse effect of obesity on cardiovascular disease (71; 72), although the current 
evidence is conflicting (10; 71-73). Similar studies have also been conducted on the risk 
of diabetes (74; 75). Although physical activity is recommended for people with 
diabetes, it is unknown whether physical activity modifies the adverse association 
between diabetes and cardiovascular disease; i.e. whether being physically active may 
compensate for the adverse association between diabetes and cardiovascular mortality 
and myocardial infarction.  
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2 Objective 
Based on The HUNT Study, the objective was to investigate the prospective association 
of diabetes on risk of death from cardiovascular disease and risk of acute myocardial 
infarction, and further, to assess how leisure time physical activity influence these 
associations. More specifically, the aims were: 
I. To examine whether leisure time physical activity could cancel out the 
adverse effect of diabetes on risk of death from cardiovascular disease. 
II. To examine whether diabetes severity, measured as medical treatment 
status and disease duration, influence the role of leisure time physical 
exercise on cardiovascular mortality. 
III. To examine whether physical activity and body mass index could modify 
the association between diabetes and risk of first acute myocardial 
infarction among people without known cardiovascular disease. 
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3 Material and methods 
3.1 Study population 
The HUNT Study is a comprehensive population based study in the Nord-Trøndelag 
County in Norway including three consecutive health surveys of the adult population, 
HUNT1 in 1984-86, HUNT2 in 1995-97, and HUNT3 in 2006-08. The county is 
located in the central part of Norway and included approximately 127,500 residents in 
1995. The population is stable (0.3% emigration per year (1996-2000)), homogenous 
(less than 3% non-Caucasians) and considered to be fairly representative for the 
Norwegian population (76). In this thesis we have used data from HUNT1 and HUNT2 
and will therefore focus on these two surveys. 
HUNT1 was conducted between January 1984 and March 1986. All inhabitants 
aged 20 years or older were invited to participate and a total of 77,216 attended (89.4% 
of those invited) (77). HUNT2 was conducted between August 1995 and June 1997. As 
in HUNT1, all inhabitants aged 20 years or older were invited to participate and a total 
of 65,237 attended (67.5% of those invited) (77).  
Participants in both HUNT1 and HUNT 2 responded to a questionnaire that was 
sent with the invitation and returned this when they attended the clinical examination. 
At the clinical examination the participants were given a second questionnaire that they 
were asked to fill in at home and return in a pre-stamped envelope. People who reported 
diabetes in the first questionnaire were also given a third questionnaire to fill in and 
return from home.  
Both HUNT1 and HUNT2 have been described in more detail elsewhere (76; 
78), and information on questionnaires and procedures can also be found on 
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www.ntnu.edu/hunt. The self-reported information and clinical measurements that we 
used in the studies forming this thesis are described in section 3.2.  
 All participants in the HUNT Study gave a written informed consent upon 
participation and the Survey was recommended by the Regional Committee for Ethics 
in Medical Research, and approved by the Norwegian Data Inspectorate. The three 
present sub studies in this thesis were approved separately by the Regional Committee 
for Ethics in Medical Research (4.2009.911).   
The HUNT Study is a collaboration between the HUNT Research Centre, 
Faculty of Medicine, Norwegian University of Science and Technology, Levanger, 
Norway, The National Institute of Public Health, the National Health Screening Service 
of Norway, and the Nord-Trøndelag County Council.  
 
 
3.2 Study variables 
3.2.1 Diabetes 
Information on diabetes diagnosis was obtained from the first questionnaire that the 
participants were given in both HUNT1 and HUNT2. Participants who answered ‘Yes’ 
to the question ‘Do you have or have you had diabetes?’ were defined as having 
diabetes.  
In HUNT2, a non-fasting whole blood sample was drawn from all participants at 
the screening site. Blood was separated by centrifuging before the serum samples were 
transported in a cooler to the Central Laboratory at Levanger Hospital and analysed on a 
Hitachi 911 Auto-analyzer (Hitachi, Mito, Japan). Glucose was measured using an 
enzymatic hexokinase method and total cholesterol using an enzymatic colorimetric 
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cholesterolesterase method. Participants who answered ‘No’ to the diabetes question 
above, but had a non-fasting glucose level ≥11mmol/l at the examination in HUNT2, 
were classified as having newly diagnosed diabetes in paper I and possible diabetes in 
paper III. 
In HUNT1, a third questionnaire was given only to persons with known diabetes 
and contained the following questions: ‘Do you take tablets for your diabetes?’, ‘Do 
you take insulin injections?’, and ‘When were you first diagnosed with diabetes?’. The 
answers to these questions provided information on use of diabetes medication and 
diabetes duration that was used in paper II. 
Those who confirmed to have diabetes in the questionnaire in HUNT2 were 
invited to a follow-up investigation, where blood glucose, serum C-peptide and 
glutamic acid decarboxylase antibodies (GADA) were measured in a fasting state.  In 
addition, GADA was analyzed in cases declaring diabetes who did not attend the 
follow-up and who had serum available from a non-fasting state. Among those 
attending the follow-up information, those with an anti-GAD level > 8,0 or an anti-
GAD < 8,0 and/or C-peptide < 150 pmol/l were classified as having type 1 diabetes. 
Among those not attending the follow-up, only the former diagnostic criteria (anti-GAD 
level > 8,0) was used to classify type 1 diabetes. This information was used in paper III. 
 
3.2.2 Leisure time physical activity 
Information on leisure time physical activity was obtained from the second 
questionnaire in HUNT1 and the first questionnaire in HUNT2. The questions about 
leisure time physical activity were different in HUNT1 and HUNT2. 
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In HUNT1, participants were asked ‘how often do you exercise (weekly average 
for the year)?’, with five response options 1) Never, 2) Less than once a week, 3) Once 
a week, 4) 2-3 times per week, or 5) Nearly every day. In the questionnaire, exercise was 
defined as ‘going for walks, skiing, swimming and working out/sports.’  Those who 
reported exercising once a week or more were also asked ‘for how long do you exercise 
each time (weekly average for the year)?’, with four mutually exclusive response 
options 1) Less than 15 min, 2) 16-30 min, 3) 30 minutes – 1 hour or 4) More than 1 
hour. For the purpose of the statistical analysis in paper II, we used the information of 
both frequency and duration of exercise to calculate ‘hours of leisure time physical 
activity per week’.The frequency response option 2–3 times per week was counted as 
2.5 times and ≥4 per week counted as five times, whereas the duration response options 
<15, 15–30, 31–60, >60 min were counted as 10, 25, 45 and 75 minutes, respectively. 
We categorized this variable into the following three categories: inactive, 0.1-1.9 hours, 
and ≥ 2.0 hours of leisure time physical activity per week. 
In HUNT2, participants were asked ‘How much of your leisure time have you 
been physically active during the last year? (Think of a weekly average for the year. 
Your commute to work counts as leisure time).’ The participants were given four 
response options for light activity 1) None, 2) Less than 1 hour, 2) 1-2 hours, or 3) ≥ 3 
hours), and the same response options for hard activity. In the questionnaire, light 
activity was defined as ‘no sweating/being out of breath’, whereas hard activity was 
defined as ‘sweating/out of breath’. For the purpose of the statistical analysis in paper I 
and III, a new variable was constructed based on the information on hours of both light 
and hard activity during a week, providing information on total leisure time activity. 
The participants were classified into the following four categories; inactive (no light or 
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hard activity), low (<3 hours light and/or <1 hour hard activity), medium (≥3 hours light 
and/or <1 hour hard activity), and high (any light and >1 hour hard activity). To 
increase statistical power in paper III, those with a low and medium level of physical 
activity were collapsed into one group (‘low/medium’). 
 
3.2.3 Other factors 
Blood pressure was measured two times in HUNT1 using a mercury manometer and 
three times in HUNT2 using a Dinamap 845XT (Critikon, Tampa, USA). From HUNT1 
we used the mean value of the first and second measurement, whereas from HUNT2 we 
used the mean value of the second and third measurement.  
Height and weight were measured in standing subjects with without shoes and 
outdoor clothing: height to the nearest centimetre and weight to the nearest half 
kilogram. Body mass index (BMI) was calculated as weight (kg) divided by the square 
value of height (m). For the purpose of the statistical analysis in paper III, people were 
defined as normal weight (<25.0 kg/m2), overweight (25-29.9 kg/m2), and obese (≥30 
kg/m2).  
Information on smoking status was obtained from the second questionnaire in 
HUNT1 and the first questionnaire in HUNT2. The participants were asked about 
current daily smoking, previous smoking, smoking cessation, amount of smoking, etc. 
Based on this information, we classified the participants in four categories of smoking; 
never, former, current, and unknown. 
Information on alcohol consumption was obtained from the second questionnaire 
in HUNT1 and the first questionnaire in HUNT2, with somewhat different questions. In 
HUNT1, the participants were asked ‘how often did you drink alcohol (beer, wine or 
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spirits) during the last 14 days?’, with five response options: 1) I did not drink alcohol, 
though I am not a non-drinker, 2) 1-4 times, 3) 5-10 times, 4)  ≥ 10 times, or  5) I am a 
non-drinker, I never drink alcohol. In HUNT2, the participants were asked ‘how many 
times a month do you normally drink alcohol?’. They could also specify if they were a 
non-drinker of alcohol. For the purpose of the statistical analyses in paper I and III we 
classified participants in HUNT2 in five categories of alcohol consumption: never, not 
the last 4 weeks, 1-3 units the last 4 weeks, more than 4 units the last 4 weeks, and 
unknown.  
Information on education was obtained from the second questionnaire in 
HUNT1 and the first questionnaire in HUNT 2. In HUNT1, the participants were asked 
‘What is your educational background? (only specify highest level achieved)’, with 
eight response options: 1) 7 years primary school or less, 2) middle school, 3) 9 years 
compulsory primary and lower secondary school, 4) 10 years primary and lower 
secondary school, 5) one or two years at upper secondary school, 6) general Certificate 
of Education, commercial college or sixth form college, 7) college or university, less 
than 4 years, or, 8) college or university, 4 years or more. In HUNT 2, the participant 
were asked ‘What is your highest level of education?’, with five response options: 1) 
primary school 7-10 years, continuation school, folk high school, 2) high school, 
intermediate school, vocational school, 1-2 years high school, 3) university qualifying 
examination, junior college, A levels, 4) university or other post-secondary education, 
less than 4 years, or, 5) university/college, 4 years or more. In the analyses we 
classified the participants in four categories of education; <10 years, 10-12 years, >13 
years, and unknown. 
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3.3 Follow up 
Every Norwegian citizen has a unique 11-digit personal identification number which 
enables linkage between the HUNT database and other health and disease registries.  
The mandatory reporting of death to the Cause of Death Registry in Norway 
constitutes the basis for the coding of underlying cause of death. Deaths were classified 
according to the International Classification of Disease (ICD-9 and ICD-10). 
Cardiovascular disease was defined by ICD-9: 390-459 and ICD-10: I00-I99, and 
ischemic heart disease by ICD-9: 410-414 and ICD-10: 120-125. In paper I and II we 
calculated individual person time at risk of death from the date of participation in 
HUNT1 (1984-86) or HUNT2 (1995-97) until the date of death or until the end of 
follow-up (31st December 2008), whichever occurred first.  
The myocardial infarctions were either identified through medical records from 
the two hospitals in Nord-Trøndelag County, or for those who never reached the 
hospital, a linkage with the Cause of Death Registry. Myocardial infarction was defined 
by ICD-9 code 410 and ICD-10 code I21, when identified through the Cause of Death 
Registry. When myocardial infarctions were identified through medical records, the 
definition included certain symptoms according to case history information, specified 
changes in blood levels of cardiac enzymes, and specified ECG changes. In paper III we 
calculated individual person time at risk from the date of participation in HUNT 2 
(1995-97) until a diagnosed first acute myocardial infarction or until the end of follow-
up (31st December 2008), whichever occurred first.  
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3.4 Statistical analyses 
We used Cox proportional hazard models to estimate adjusted hazard ratios (HRs) of 
death from cardiovascular disease or from fist acute myocardial infarction, according to 
diabetes and leisure time physical activity.  
In paper I, we estimated HRs of death from cardiovascular disease associated 
with diabetes, and in separate analyses, assessed the combined association of diabetes 
and leisure time physical activity on risk of death from cardiovascular disease.  
In paper II, we estimated HRs of death from cardiovascular disease and 
ischaemic heart disease associated with diabetes treatment (with or without oral 
hypoglycemic drugs or insulin) and disease duration, and in a separate analysis, 
assessed the combined association of leisure time physical exercise and diabetes 
treatment with risk of death. 
In paper III, we estimated HRs of first acute myocardial infarction associated 
with diabetes, and in separate analyses, assessed the combined association of leisure 
time physical activity and diabetes, as well as body mass index and diabetes, with the 
risk of acute myocardial infarction. We also combined information on body mass index 
and leisure time physical activity to examine risk of acute myocardial infarction among 
people with diabetes. 
Precision of the estimated hazard ratios was assessed by a 95% confidence 
interval (CI). Departure from the proportional hazards assumption was evaluated by 
Schoenfeld residuals and graphical procedures (log-log plots). All estimated 
associations were adjusted for age (as the time scale) and other possible confounding 
factors. In the analyses of the combined associations of diabetes and physical activity, 
we adjusted for sex in a pooled sample to increase statistical power. We used a 
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likelihood ratio test to assess statistical interaction (i.e. departure from a multiplicative 
effect) between diabetes and sex, and between diabetes and physical activity. The 
association between physical activity and risk of death from cardiovascular disease or 
risk of acute myocardial infarction was assessed in analyses stratified by diabetes status.  
In paper I, a test for linear trend across categories of physical activity was 
conducted by treating the categories as an ordinal variable in the regression model. In 
paper III, we estimated the relative excess risk due to interaction (RERI) between 
physical activity and diabetes, as wells as between body mass index and diabetes. 
Additional sensitivity and subgroup analyses were conducted when appropriate. All 
statistical tests were two-sided. 
The data in paper I were analysed using Stata for Windows, version 10.0 and the 
data in paper II and III were analysed using Stata for Windows, version 11.2 (StataCorp, 
Texas, USA). 
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4 Main results 
4.1 Paper I: The combined effect of leisure time physical activity and 
diabetes on cardiovascular mortality: the HUNT cohort study, 
Norway. 
We examined whether leisure time physical activity could cancel out the adverse effect 
of diabetes on the risk of death from cardiovascular disease. 
Data on 53,587 participants in the HUNT 2 Study (1995-97) were linked with 
the Cause of Death Registry. During a median follow-up of 12.0 years, 1,716 people 
died from a cardiovascular disease. Both men and women with diabetes (N = 1,195) had 
a higher risk of death from cardiovascular disease than people without diabetes. The 
adjusted HR was 1.72 (95% CI: 1.37, 2.16) in men and 1.96 (95% CI: 1.55, 2.50) in 
women. Compared to the reference group of physically inactive people without 
diabetes, inactive people with diabetes had an adjusted HR of 2.81 (95% CI: 1.93, 4.07). 
Persons with diabetes who reported 1-2 hours per week of light activity had 
approximately similar risk as the reference group (HR, 1.07; 95% CI: 0.63, 1.81), and 
the risk was further reduced among persons with diabetes who reported ≥3 hours of 
light activity (HR, 0.89; 95% CI: 0.48, 1.63). The HR among persons without diabetes 
who reported ≥3 hours per week of light activity was 0.78 (95% CI:  0.63, 0.96). There 
was statistical evidence for a dose-response effect of light physical activity, both among 
persons with (Ptrend, <0.001) and without (Ptrend, 0.007) diabetes. Analyses stratified by 
total activity level showed a gradually reduced association of diabetes with mortality 
with increasing activity level (Pinteraction = 0.003). In sensitivity analyses, we excluded 
the first five years of follow up, and then also people who reported a moderate or high 
degree of movement disability. Both analyses gave largely similar results as those 
presented above. 
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4.2 Paper II: Diabetes severity and the role of leisure time physical 
activity on cardiovascular mortality: the Nord-Trøndelag Health study 
(HUNT), Norway. 
We examined whether diabetes severity, measured as medical treatment status and 
disease duration, influence the role of leisure time physical exercise on cardiovascular 
mortality. 
 Data on 56,170 participants in the HUNT 1 Study (1984-86) were linked with 
the Cause of Death Registry. During a median follow-up of 23.8 years, 7,723 people 
died from a cardiovascular disease. Both men and women with diabetes (N = 1,105) had 
a higher risk of death from cardiovascular disease than people without diabetes. 
Compared to people without diabetes, the adjusted HR for cardiovascular death was 
1.59 (95% CI: 1.29, 1.96) among men with diabetes who received no medical treatment, 
and 2.16 (95% CI: 1.80, 2.60) for men with diabetes who used medication. The adjusted 
HR for cardiovascular death was 1.64 (95% CI: 1.34, 2.00) in diabetic women without 
medication and 2.85 (95% CI: 2.43, 3.34) for those who used medication. In people 
with diabetes who did not use medication, the adjusted HR for cardiovascular death was 
1.65 (95% CI: 1.34, 2.03) for inactive people and 0.99 (95% CI: 0.68, 1.45) for those 
who reported ≥ 2.0 hours of leisure time physical exercise per week. Among people 
with more severe diabetes (i.e. those who used medication), the adjusted HR for 
cardiovascular death was 2.46 (95% CI: 2.08, 2.92) in people who were inactive and 
1.58 (95% CI: 1.21, 2.05) for those who reported ≥ 2.0 hours of leisure time physical 
exercise per week. People with diabetes who exercised 0.1-1.9 hours per week had 
approximately similar HRs as those who were inactive. A similar pattern was observed 
for death from ischaemic heart disease, although the difference in HRs between inactive 
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people and the most active were somewhat larger. The results remained similar in 
sensitivity analyses were we excluded the first five years of follow up, and also after 
excluding people who reported a moderate or high degree of movement disability. 
 
4.3 Paper III: The adverse association of diabetes on first acute 
myocardial infarction is modified by physical activity and body mass 
index. Prospective data from the HUNT Study, Norway. 
We examined whether physical activity and body mass index could modify the 
association between diabetes and risk of first acute myocardial infarction among people 
without existing cardiovascular disease.  
Data on 55,534 participants in the HUNT 2 Study (1995-97) were linked with 
hospital admission registries and the Cause of Death Registry. During a median follow-
up of 12.3 years, 1,887 persons had been diagnosed with a first acute myocardial 
infarction. Both men and women with diabetes had a higher risk of acute myocardial 
infarction than people without diabetes. The adjusted HR was 1.49 (95% CI: 1.20, 1.86) 
in men and 2.76 (95% CI: 2.17, 3.51) in women. People with diabetes who were 
classified as highly active (i.e. at least 1 hour of hard activity) had similar risk (HR: 
1.04; 95% CI: 0.62, 1.73) as the reference group of inactive people without diabetes. 
The corresponding HR among persons without diabetes who were highly active was 
0.77 (95% CI: 0.64, 0.94). Total physical activity was inversely and dose-dependently 
associated with risk of acute myocardial infarction in both people with diabetes (Ptrend 
=0.019) and in people without diabetes (Ptrend = 0.010). Sensitivity analyses were we 
first excluded 185 persons who were likely to have diabetes type 1 and second, 
excluded the first three years of follow up to avoid possible bias by pre-clinical disease, 
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gave largely similar results to those presented above. The data suggest biological 
interaction between diabetes and physical activity, with a relative excess risk of 
inactivity and diabetes of 1.43 (95% CI: 0.08-2.78). Compared to normal weight people 
(< 25 kg/m2) without diabetes, normal weight people (BMI <25 kg/m2) with diabetes 
had a HR of 1.61 (95% CI: 1.06-2.45) and obese people (BMI >30 kg/m2) with diabetes 
had a HR of 2.57 (95% CI: 1.99, 3.31). For obesity and diabetes, the excess risk due to 
interaction was smaller (0.67; 95% CI: -0.24-1.58).  
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5 Discussion 
In the studies included in this thesis we have attempted to use epidemiologically sound 
methods to achieve accurate estimates of how leisure time physical activity influence 
the adverse association of diabetes and risk of cardiovascular death, and on risk of a first 
acute myocardial infarction. Briefly, the main findings were: 
- Even modest physical activity may cancel out the adverse association of 
diabetes on cardiovascular mortality. 
- The favorable effect of exercise in people with diabetes is especially strong 
among people with diabetes using medical treatment compared to those 
without medical treatment. 
- Body weight, and in particular physical activity, modified the association 
between diabetes and risk of first acute myocardial infarction. 
 
When interpreting the results of our studies, it should be noted that they could be distorted by 
random error, which reduces the precision of the associations, or by systematic error which 
interferes with the validity of the results (79). These topics are further discussed below.  
 
5.1 Random error (lack of precision) 
Random error is the fluctuation in the observed value from the true value due to any 
factors caused by chance (80). We have used a relatively large study population, which 
should reduce the impact of random error. This is indicated by the narrow confidence 
intervals around the point estimates in most of the analyses. However, some of the more 
infrequent exposure categories had relatively few cases, leading to less precise estimates 
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for some of the comparisons. For this reason, we performed analyses of the joint 
association of diabetes and physical activity on a pooled sample of men and women, 
adjusting for sex in the regression model. Thus, possible effect modification by sex 
could not be adequately inferred in these data.  
 
5.2 Systematic error (lack of validity) 
Systematic errors in estimates could have several sources, such as how the subjects 
were selected, how the study variables were measured, and by incomplete control of 
confounding factors (80).  
 
5.2.1 The role of selection bias 
Selection bias would influence the validity of our result if the observed associations 
were different for the participants of the study and the theoretically eligible non-
participants. In HUNT 1, the participation rate was 89.4 %, whereas the participation 
rate in HUNT 2 was 67.5 %. The high participation rates indicate that the study cohort 
is fairly representative for the underlying population, and reduce the likelihood of 
selection bias. However, studies of the non-responders in both HUNT 1 and HUNT 2 
have shown that non-responders had lower socio-economic status, higher mortality and 
were more likely to have diabetes and cardiovascular disease than participants (76; 81). 
Although, possible selection bias cannot be ruled out, it has been argued that 
representativeness is not a prerequisite for valid results (82). 
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5.2.2 The role of information bias 
Information bias (or misclassification) would influence the validity of our result if the 
variables under study have been measured randomly or systematically wrong. The 
assessment of diabetes status, leisure time physical activity, cardiovascular deaths and 
acute myocardial infarctions are all prone to measurement error. 
The self-reported diagnosis of diabetes in the HUNT Study was validated in a 
separate study (83), showing that 96.4 % of the self-reported diabetes could be verified 
in medical files. Other studies have also verified the diagnosis in 97% of the cases (56; 
84). Participants who answered ‘No’ to the question of having diabetes, but had a non-
fasting glucose level ≥11mmol/l at the examination in HUNT2 were classified as having 
newly diagnosed diabetes in paper I and III. A similar procedure has also been used in 
previous studies (13; 85; 86). Ideally, this criterion should be accompanied by 
information on symptoms of diabetes (e.g. polyuria) (13), but this information was not 
available. Still, unknown diabetes could have underestimated the association between 
diabetes and cardiovascular disease. In the self-reported assessment of diabetes 
treatment and disease duration, misclassification could not be ruled out.  
The questions about leisure time physical activity were validated in separate 
studies of young adult men by comparison with more objective measures of fitness and 
activity, such as VO2max and ActiReg (87; 88). The questions in HUNT1 were 
reported to have good repeatability and provide a useful measure of leisure time 
physical exercise (87). In HUNT2, the question about hard activity was found to have 
acceptable repeatability and provide a valid measure of vigorous activity, shown by 
moderate correlations with VO2max, whereas light activity showed no correlation and 
had poor reproducibility (88). Although not sufficient to increase cardiorespiratory 
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fitness, light activity could elicit other biological mechanisms that are beneficial for 
cardiovascular health (e.g. improved glycaemic control). In both HUNT1 and HUNT2, 
possible subjective interpretation of the questions and perception of the activity can be 
influenced by factors such as age, social context, and seasonal variation (89), and in our 
studies, by diabetes status, duration, and treatment. However, it is unlikely that an over 
reporting of the activity level would overestimate the effect of physical activity, as 
indicated in a previous study with measures of both fitness and activity (90). Non-
differential measurement error of physical activity between people with and without 
diabetes would most likely cause bias towards the null value, thereby leading to 
underestimation of the associations. On the other hand, if people with diabetes classified 
their physical activity differently than people without diabetes, the results may be 
biased. Nevertheless, validation studies have shown that questionnaires are valid for 
large epidemiological studies attempting to classify individuals into broad categories of 
physical activity (e.g., low, moderate, and high activity) (91).  
There may also be errors in the classifications of death from cardiovascular 
disease. Older people, and in particular those with diabetes, could be prone to this 
misclassification. This would overestimate the association between diabetes and death 
from cardiovascular disease. The overall validity of the Cause of Death Registry has not 
been assessed, but meticulous coding systems has been implemented to facilitate high 
data quality (92).  
Diabetes status and leisure time physical activity was only assessed at baseline, 
and does therefore not take into account individual changes over time. Studies have 
shown that the prevalence of diabetes has gradually increased in the population (2; 93). 
Thus, people who were diagnosed with diabetes during the follow-up may have inflated 
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the risk in the reference group of people without diabetes at baseline, attenuating the 
association between diabetes and cardiovascular disease. It is also possible that the 
people who were diagnosed with diabetes at baseline would change their level of 
physical activity as a result. However, a sensitivity analysis in paper I were we excluded 
people with newly diagnosed diabetes gave similar results to those observed for the total 
diabetes group.  
 
5.2.3 The role of confounding 
Confounding would influence the validity of our results if the observed associations 
between diabetes, physical activity and cardiovascular disease are totally or partly due 
to some other extraneous factor(s) not completely controlled for in the analyses. 
 Selection of possible confounders was done based on a priori knowledge about 
factors that could be related both to diabetes and cardiovascular disease. 
 Both diabetes and cardiovascular disease is strongly associated with increasing 
age. Therefore, we adjusted for attained age (as the time scale) in all analyses. In paper 
II and III, we additionally adjusted for birth cohort (5 year strata) to take into account 
that possible secular trends in diagnoses and treatment of diabetes could influence the 
observed associations.  
We found a stronger association between diabetes and cardiovascular death and 
acute myocardial infarction in women than in men. However, the sex specific analyses 
of the combined association of diabetes and physical activity had low statistical power 
(e.g. no women with diabetes and a high level of physical activity had acute myocardial 
infarction in paper III). Thus, the main results are based on the pooled sample, adjusting 
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for sex. As mentioned previously, this implies that the role of physical activity may be 
somewhat different between men and women.  
 We also considered smoking, alcohol consumption, education, body mass index, 
systolic blood pressure and total serum cholesterol as possibly confounding variables 
and adjusted for them in the analyses. However, in paper II we did not have information 
about total serum choleterol from HUNT1, so this variable could not be controlled for. 
Also, residual confounding due to unknown, unmeasured, or poorly measured 
(misclassified) factors cannot be ruled out. 
Some of the factors that we adjusted for could be on the causal pathway between 
physical activity and cardiovascular disease (e.g. body mass index and systolic blood 
pressure). Adjusting for such mediators could underestimate the true effect. However, 
the small difference between age and multivariably adjusted estimates suggests that this 
is not likely.  
Diabetes, or survival until onset of diabetes, could be a collider (caused by two 
factors, e.g., physical activity and some other risk factor) so that stratification may 
induce an association between physical activity and another risk factor, potentially 
biasing the association of physical activity with the outcome (94). 
 
5.3 Appraisal of the principal findings 
In paper I, we found an approximately two-fold increase in risk of death from 
cardiovascular disease among persons with diabetes. This is in accordance with 
previous prospective cohort studies, including The Reykjavik Study (43), the NHANES 
1 study (46), the Framingham Heart Study (47), and studies from the first HUNT survey 
(44; 49), reporting a 2-4 fold increased risk of cardiovascular death in people with 
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diabetes. The results from paper II, are also in agreement with previous prospective 
studies, showing that people with diabetes treated with oral hypoglycemic drugs or 
insulin have a higher risk of death from cardiovascular disease than those without 
medication (54; 55). Several studies have reported a positive association between 
diabetes duration and cardiovascular mortality (56-59; 61), but we did not find any 
strong effect of diabetes duration on cardiovascular mortality when diabetes treatment 
was taken into account. Furthermore, similar to the results in paper III, previous studies 
have showed that diabetes increase the risk of acute myocardial infarction (95-97). In all 
three papers, the associations between diabetes and the outcome were stronger among 
women than men. This is in accordance with other studies (48; 49; 96; 97), suggesting 
that treatment of cardiovascular risk factors could favour men more than women, and 
that women with diabetes have more adverse cardiovascular risk profiles (48). 
To our knowledge, paper I is first to show that even modest physical activity 
may cancel out the adverse association between diabetes and cardiovascular mortality, 
paper II is first to show a differential effect of physical exercise on cardiovascular 
mortality by diabetes severity, and paper III is first to show that physical activity and 
body mass index modifies the association between diabetes and risk of a first acute 
myocardial infarction among people with diabetes. Similar to our studies, previous 
studies have shown that increasing levels of physical activity are associated with lower 
risk of cardiovascular death among people with diabetes (8; 9) and in the general 
population (10; 11). Comparisons between studies are difficult due to different methods 
of assessing physical activity. Nevertheless, it has been shown that the most physically 
active persons with diabetes have approximately half the risk compared to inactive 
diabetics (8; 9). Also, people with diabetes and a low body mass index have been 
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reported to have lower risk of death from cardiovascular disease, than obese people with 
diabetes (51).  
There are several possible mechanisms that could explain how physical activity 
reduces the risk of cardiovascular death among persons with diabetes. Physical activity 
may improve glycaemic control, insulin sensitivity, blood pressure, lipid profile, and 
body composition in people with diabetes (62-65).  Prospective studies have shown a 
weak independent association between hyperglycaemia and risk of cardiovascular 
disease in persons with diabetes (44; 98). High cholesterol levels increase the risk of 
cardiovascular disease, both in persons with (14, 39) and without (9; 98; 99) diabetes, as 
do high blood pressure and body mass index (9). Also, people with a normal body mass 
index have better glycemic control, insulin sensitivity, blood pressure and lipid profile 
than their obese counterparts (3; 100-102). This indicates that physical activity and 
maintaining a normal body mass index are two interrelated and modifiable risk factors 
that deserve increased attention in diabetes management. Thus it is likely, that the 
beneficial effect of physical activity may be explained by the sum of improvements in 
several conventional cardiovascular disease risk factors.  
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5.4 Conclusion and implications 
We found that inactive persons with diabetes had almost three-fold higher risk of 
cardiovascular death compared with those without diabetes. The excess risk was 
reduced with increasing amount of leisure time physical activity and the results suggest 
that 1-2 hours of non-vigorous activity may be sufficient to obtain a favourable effect. 
We also found a more beneficial effect of physical exercise on risk of death from 
cardiovascular disease in people with more severe diabetes, measured as medical 
treatment status. Finally, we found that the excess risk of acute myocardial infarction 
associated with diabetes was cancelled out among those who reported a high physical 
activity level. Moreover, a normal body weight was also associated with lower risk of 
first AMI, especially when combined with a moderate or high level of physical activity. 
 Our results highlight the importance of leisure time physical activity and weight 
maintenance as effective means for primary prevention of risk of death from 
cardiovascular disease and risk of acute myocardial infarction among people with 
diabetes. Furthermore, our results suggest that the favourable effect of physical activity 
should be within reach for most people with diabetes and should be more strongly 
encouraged as effective means of primary prevention additional to medical treatment.  
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Paper I
The Combined Effect of Leisure Time
Physical Activity and Diabetes on
CardiovascularMortality
The Nord-Trøndelag Health (HUNT) cohort study, Norway
BØRGE MOE, MS
EIVIN EILERTSEN, MS
TOM I.L. NILSEN, PHD
OBJECTIVEdTo examine if leisure time physical activity could cancel out the adverse effect of
diabetes on cardiovascular mortality.
RESEARCH DESIGN AND METHODSdThis study prospectively examined the com-
bined effect of clinical diabetes and reported leisure time physical activity on cardiovascular
mortality. Data on 53,587 Norwegian men and women participating in the population-based
Nord-Trøndelag Health (HUNT) Study (1995–1997) were linked with the Cause of Death Reg-
istry at Statistics Norway.
RESULTSdOverall, 1,716 people died of cardiovascular disease during follow-up through
2008. Compared with the reference group of 3,077 physically inactive people without diabetes,
121 inactive people with diabetes had an adjusted hazard ratio (HR) of 2.81 (95%CI 1.93–4.07).
The HR (95% CI) among people who reported $3 h of light activity per week was 0.89 (0.48–
1.63) if they had diabetes (n = 403) and 0.78 (0.63–0.96) if they did not (n = 17,714). Analyses
stratiﬁed by total activity level showed a gradually weaker association of diabetes with mortality
with increasing activity level (Pinteraction = 0.003).
CONCLUSIONdThe data suggest that even modest physical activity may cancel out the
adverse impact of diabetes on cardiovascular mortality.
Many studies have shown that theincidence of diabetes has in-creased during the past decades
(1–3), in parallel to the increase in obesity
that is observed in most developed coun-
tries (4,5). Several studies have shown
that diabetes approximately doubles the
risk of death from cardiovascular disease
(6–11).
There is less evidence that physical
activity has favorable effects on cardio-
vascular disease risk and mortality among
people with diabetes (12,13), but physical
activity has been shown to improve gly-
cemic control and several cardiovascular
risk factors in people with diabetes (14–
17). Current guidelines recommend an
even higher level of physical activity for
people with diabetes than for the general
population (18,19). However, it is un-
known whether physical activity could
reduce the excess cardiovascular mortal-
ity in people with diabetes beyond the ef-
fect observed among those without
diabetes. A few previous studies have
shown that physical activity may com-
pensate for the adverse effects of other
cardiovascular risk factors, such as obe-
sity (20) and hypertension (21).
A recent report indicated that people
with a clustering of cardiovascular risk
factors who were highly physically active
had the same risk of death from ischemic
heart disease and stroke as healthy indi-
viduals who reported no physical activity
(22). The aim of this prospective study
was therefore to investigate the combined
effect of leisure time physical activity and
diabetes with respect to cardiovascular
mortality and to assess if physical activity
could cancel out the adverse effect of di-
abetes.
RESEARCH DESIGN AND
METHODSdThe Nord-Trøndelag
Health (HUNT) Study is a large population-
based health survey in Nord-Trøndelag
County in Norway. Between 1995 and
1997, all inhabitants aged 20 years or
older were invited to participate in the sec-
ond wave of the study (HUNT 2). Among
94,194 eligible participants, 65,361
(70%) accepted this invitation, completed
questionnaires, and attended a clinical ex-
amination (34,786 women and 30,575
men). From this original cohort, 11,774
participants were excluded at baseline:
5,186 who reported prevalent cardiovas-
cular disease (angina, myocardial infarc-
tion, and/or stroke), 6,060 without
information on physical activity, 32 with-
out information on diabetes status, and
496 without information on potentially
confounding factors. After these exclu-
sions, 53,587 participants (25,159 men
and 28,428 women) were available for
follow-up on cause of death. The HUNT
Study is a collaboration between the
HUNT Research Centre, Faculty of Medi-
cine, Norwegian University of Science and
Technology, Verdal, Norway, The Na-
tional Institute of Public Health, the Na-
tional Health Screening Service of
Norway, and the Nord-Trøndelag County
Council.
A detailed description of selection
procedures, questionnaires, and meas-
urements can be found at http://www
.ntnu.edu/hunt and in Holmen et al.
(23). Brieﬂy, information was collected
on a range of lifestyle and health-related
factors, including medical history, physi-
cal activity, smoking status, alcohol con-
sumption, and educational attainment. At
the clinical examination, standard an-
thropometric measures were obtained in
standing subjects without shoes (height
c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c c
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to the nearest centimeter, weight to the
nearest half kilogram, and waist and hip
circumference to the nearest centimeter).
Blood pressure was measured three times
using a Dinamap 845XT (Critikon,
Tampa, FL), and the mean of the second
and third measure was calculated. A non-
fasting whole-blood sample was drawn
from all participants at the screening
site. Blood was separated by centrifuging
before the serum samples were transpor-
ted in a cooler to the Central Laboratory at
Levanger Hospital and analyzed on a Hi-
tachi 911 Auto-analyzer (Hitachi, Mito,
Japan). Glucose was measured using an
enzymatic hexokinase method and total
cholesterol using an enzymatic colorimet-
ric cholesterol esterase method.
Diabetes status was deﬁned by two
methods: First, participants who answered
“Yes” to the question “Do you have or have
you had diabetes?” were deﬁned as having
diabetes. The self-reported diagnosis of di-
abetes in HUNTwas validated in a separate
study (24), showing that 96.4% of the self-
reported diabetes could be veriﬁed inmed-
ical ﬁles. People who answered “No” to the
diabetes question, but who presented
with a nonfasting glucose level $11
mmol/L at the examination, were classiﬁed
as having newly diagnosed diabetes. A sim-
ilar procedure has been used in previous
studies (25–27). Ideally, this criterion
should be accompanied by information
on symptoms of diabetes (e.g., polyuria)
(27), but this information was not avail-
able.
Information on leisure-time physical
activity was obtained from the standard
questionnaire. Participants were asked to
report their usual weekly hours of light
and/or hard leisure-time physical activity
during the past year, with four response
options (0, ,1, 1–2, and$ 3 h) for light
activity and the same response options for
hard activity. The questionnaire deﬁned
light activity as “not sweating/being out of
breath,” whereas hard activity was de-
ﬁned as “sweating/out of breath.” We
did not have information about metabolic
equivalent of task (MET), therefore the
terms light and hard physical activity
should not be interpreted as categories
conventionally deﬁned by METs.
For the purpose of the statistical
analysis, a new variable was constructed
based on the information on hours of light
and hard activity during a week, pro-
viding information on total leisure time
activity. The participants were classiﬁed
into four categories: inactive (no light or
hard activity), low (,3 h light and/or
,1 h hard activity), medium ($3 h light
and/or,1 h hard activity), and high (any
light and .1 h hard activity).
Individual person-time at risk for
death was calculated from the date of
participation in the HUNT 2 study
(1995–1997) until the date of death or un-
til the end of follow-up (31 December
2008), whichever occurred ﬁrst. The man-
datory reporting of death toCause ofDeath
Registry at Statistics Norway constitutes
the basis for the coding of underlying cause
of death. Deaths were classiﬁed according
to the ICD-9 and ICD-10. Cardiovascular
disease was deﬁned by ICD-9 codes 390–
459 and ICD-10 codes I00–I99.
Statistical analysis
A Cox proportional hazard model was
used to estimate adjusted hazard ratios
(HRs) of death from cardiovascular disease
associated with diabetes, and in a separate
analysis, to assess the combined effect of
physical activity and diabetes on risk of
death from cardiovascular disease. Preci-
sion of the estimatedHRswas assessed by a
95% CI. All estimated associations were
adjusted for the potential confounding
effect of age (as the time scale), smoking
status (never, former, current, unknown),
alcohol consumption (never, not the last 4
weeks, 1–3 units the last 4weeks,.4units
the last 4 weeks), education (,10, 10–12,
.13 years, unknown), BMI (kg/m2), sys-
tolic blood pressure (mmHg), and total se-
rum cholesterol (mmol/L).
In addition, we controlled for total
physical activity level (inactive, low, me-
dium, high) when analyzing the indepen-
dent effect of diabetes. The latter analyses
were conducted separately for men and
women, whereas in analyses of the com-
bined effect, we adjusted for sex in a
pooled sample necessary for statistical
power. This pooling was justiﬁed by
log-likelihood tests of interaction be-
tween diabetes and sex (P = 0.17). Al-
though physical activity and sex showed
weak evidence of interaction (P = 0.08),
the associations were not largely different
in men and women. A test for linear trend
across categories of physical activity was
conducted by treating the categories as an
ordinal variable in the regression model.
To examine if physical activity could
modify the association between diabetes
and cardiovascular mortality, we conduc-
ted stratiﬁed analyses and tested statistical
interaction (departure from a multiplica-
tive effect) between diabetes and physical
activity in a likelihood ratio test. Further-
more, we conducted a competing-risks
analysis according to the method of Fine
and Gray (28) to explore whether our re-
sults could be biased by deaths from cau-
ses other than cardiovascular disease.
Departure from the proportional haz-
ards assumption was evaluated by
Schoenfeld residuals and graphical pro-
cedures (log-log plots). All statistical tests
were two-sided, and all analyses were
conducted using Stata 10.0 software (Sta-
taCorp, College Station, TX).
The study was approved by the Re-
gional Committee for Ethics in Medical
Research, and all HUNT 2 Study partic-
ipants gave a written consent.
RESULTSdTable 1 reports baseline
characteristics of the study population.
During a median follow-up of 12.0 years
(642,888 person-years), 1,716 people
Table 1dBaseline characteristics of the study population
Characteristics
Men Women
Diabetes No diabetes Diabetes No diabetes
n = 636 n = 24,523 n = 559 n = 27,869
Age at study entry
(mean [SD] years) 59.0 (14.7) 46.2 (15.3) 61.8 (15.2) 46.1 (15.7)
BMI (mean [SD] kg/m2) 28.1 (4.3) 26.3 (3.4) 29.8 (5.7) 25.9 (4.4)
Systolic blood pressure
(mean [SD] mmHg) 150.1 (21.8) 138.4 (17.7) 154.0 (25.7) 132.1 (21.6)
Total cholesterol
(mean [SD] mmol/L) 5.83 (1.20) 5.76 (1.15) 6.35 (1.31) 5.81 (1.29)
High physical activity levela (%) 22.8 34.4 10.7 22.8
BMI $ 30 kg/m2 (%) 28.9 13.1 43.2 16.2
Current smoker (%) 26.9 29.2 15.6 31.1
High alcohol consumptionb (%) 14.5 18.0 3.9 7.9
aAt least “1–2 h or more” of vigorous physical activity each week. bFour times or more during the last month.
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died of a cardiovascular disease (956 men
and 760 women). Compared with the
6,588 participants who were excluded
due to missing values on central variables,
the 53,587 responders were, on average,
younger (mean age, 46.5 vs. 64.5 years)
and were less likely to die of cardiovascu-
lar disease (age- and sex-adjustedHR 0.74
[95% CI 0.68–0.80]). There was no evi-
dence of departure from the proportional
hazards assumption for any of the expo-
sure variables under study.
The men and women with diabetes
(N = 1,195) had a higher risk of death
from cardiovascular disease than those
without diabetes (Table 2). The adjusted
HR (95% CI) was 1.72 (1.37–2.16) in
men and 1.96 (1.55–2.50) in women.
In a sensitivity analysis, we excluded the
201 people with newly diagnosed diabe-
tes based on a nonfasting glucose .11.0
mmol/L, but the HRs (95% CIs) remained
largely similar to those observed for the
total diabetes group: 1.76 (1.38–2.25) in
men and 2.01 (1.57–2.57) in women
(data not shown).
Table 3 reports the combined effect of
diabetes and physical activity on cardio-
vascular mortality using the 3,077 inac-
tive people without diabetes as the
reference group for all comparisons. First,
we analyzed the effect of diabetes in com-
bination with light physical activity (i.e.,
no sweating/not being out of breath)
among people who reported no hard ac-
tivity (i.e., sweating/being out of breath)
per week. Compared with the reference
group, inactive people with diabetes
had a HR (95% CI) of 2.81 (1.93–4.07).
People with diabetes who reported 1–2 h
per week of light activity had approxi-
mately similar risk as the reference group
(1.07 [0.63–1.81]), and the risk was fur-
ther reduced among people with diabetes
who reported$3 h of light activity (0.89
[0.48–1.63]). Among people without di-
abetes who reported $3 h per week of
light activity, the HR (95% CI) was 0.78
(0.63–0.96). There was statistical evi-
dence for a dose–response effect of light
physical activity among people with
(Ptrend , 0.001) and without (Ptrend =
0.007) diabetes.
Second, we analyzed a total physical
activity variable that incorporated light
and hard activity. Compared with the
reference group, people with diabetes
who were classiﬁed as highly active (i.e.,
at least 1 h of hard activity) had aHR (95%
CI) of 0.91 (0.51–1.60), whereas among
highly active people without diabetes this
was 0.66 (0.53–0.81). Total physical ac-
tivity also showed a dose-response rela-
tion to cardiovascular mortality (Ptrend
, 0.001 in both groups). Age- and sex-
adjusted estimates were largely similar to
the multivariably adjusted results, indi-
cating little confounding and/or low me-
diating effects of these variables. Because
few people reported that they only en-
gaged in hard activity (i.e., no light activ-
ity), the data did not allow us to assess the
separate effect of hard activity.
There was statistical evidence of in-
teraction between diabetes and total
physical activity level (P = 0.03), suggest-
ing that the adverse effect of diabetes on
cardiovascular mortality was smaller
among active than among inactive people.
This was also suggested from analyses
stratiﬁed by total physical activity level:
diabetes was associated with a HR (95%
CI) of 2.76 (1.88–4.07) among inactive
persons and 1.88 (1.47–2.39), 1.43
(1.02–2.00), and 1.34 (0.75–2.39)
among people with low, medium, and
high activity levels, respectively (data
not shown).
It is conceivable that our results could
be biased by severity of disease (i.e., those
who are least active may have poorly
controlled diabetes). To explore this we
conducted a supplementary stratiﬁed
analysis excluding the ﬁrst 5 years of
follow-up. The results did not substan-
tially deviate from the results presented
above: diabetes was associated with a HR
(95% CI) of 3.24 (1.94–5.43) among in-
active persons and 1.75 (1.29–2.38), 1.29
(0.85–1.97), and 1.22 (0.61–2.46)
among people with low, medium, and
high activity level, respectively (data not
shown).
We also did a stratiﬁed analysis ex-
cluding people reporting a moderate or
high degree of movement disability. In
this analysis, diabetes was associated
with a HR (95% CI) of 2.61 (1.65–4.14)
among inactive people and 1.70 (1.30–
2.23), 1.40 (0.96–2.04), and 1.26
(0.67–2.37) among people with low, me-
dium, and high activity levels, respec-
tively (data not shown). Corresponding
analyses accounting for potential compet-
ing risk from other causes of death than
cardiovascular disease gave largely similar
associations. The HR (95% CI) among in-
active people was 2.72 (1.91–3.87) and
1.90 (1.40–2.42), 1.44 (1.02–2.04), and
1.55 (0.89–2.71) among those with low,
medium, and high activity levels, respec-
tively (data not shown).
DISCUSSIONdIn this largepopulation-
based cohort study, people with diabetes
had a nearly twofold higher risk of death
from cardiovascular disease than people
without diabetes, with a slightly stronger
association among women than among
men. Diabetes was associatedwith a nearly
threefold higher risk among people who
reported being physically inactive. The
risk of death from cardiovascular disease
among people with diabetes who re-
ported amoderate to high physical activity
level was similar to inactive people with-
out diabetes.
The strengths of this study include
the population-based sample, the pro-
spective design, the large number of
participants, and ascertainment of total
and cardiovascular death through the
Cause of Death Registry at Statistics Nor-
way. The latter allows for a complete
Table 2dHRs for death from cardiovascular disease associated with diabetes
Diabetes status
Men Women
Person-years Deaths HRa HRb 95% CI Person-years Deaths HRa HRb 95% CI
N N
No diabetes 292,792 873 1.00 1.00 Reference 337,509 681 1.00 1.00 Reference
Diabetes 6,668 83 1.67 1.72 1.37–2.16 5,908 79 2.04 1.96 1.55–2.50
aAdjusted for age (as the time scale). bAdjusted for age (as the time scale), physical activity level each week (inactive, low, medium, high), smoking status (never,
former, current, unknown), alcohol consumption (never, not the last 4 weeks, 1–3 units the last 4 weeks,.4 units the last 4 weeks), education (,10, 10–12,.13
years, unknown), BMI (kg/m2), systolic blood pressure (mmHg), and total serum cholesterol (mmol/L).
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measure of outcome and practically no
dropouts throughout the median 12-year
follow-up period. An additional strength
is the large number of potential con-
founding factors that were available.
Limitations of the study include the
somewhat low precision of effect esti-
mates in some of the categories in the
combined analysis due to few deaths
(32% of all deaths) from cardiovascular
disease. Also, leisure-time physical activ-
ity was self-reported and only assessed at
baseline, without follow-up information.
Possible subjective interpretation of the
questions and perception of the activity
can be inﬂuenced by factors such as age,
social context, and seasonal variation
(29), and in the current study, by known
diabetes status, duration, and severity.
However, it is unlikely that an over-
reporting of the activity level would over-
estimate the effect of physical activity, as
indicated in a previous study with meas-
ures of both ﬁtness and activity (30). The
physical activity questions in the current
study did not distinguish between differ-
ent types of leisure-time physical activity.
Consequently, the speciﬁc effect of aero-
bic versus resistance training could not be
estimated.
The activity questions have been val-
idated in a separate study of young adult
men by comparison with VO2max, Ac-
tiReg, and with the International Physical
Activity Questionnaire. Hard activity was
found to correlate well with VO2max
(Pearson correlation coefﬁcient = 0.46),
whereas light activity showed no correla-
tion (20.03) (31). Although not sufﬁ-
cient to increase cardiorespiratory
ﬁtness, light activity could elicit other
adaptions. However, the validation study
showed only a weak correlation between
reported light activity and energy expen-
diture measuredwith ActiReg (0.21) (31).
Nevertheless, validation studies have
shown that questionnaires are most prac-
tical for large epidemiological studies at-
tempting to classify individuals into
categories of physical activity (e.g., low,
moderate, and high activity) (32).
Furthermore, it is curious that the
prevalence of diabetes has increased only
slightly during the 12-year follow-up
(33). It is possible that unknown diabetes
could over- or underestimate the associa-
tion between diabetes and cardiovascular
mortality. Unfortunately, updated infor-
mation on diabetes status and physical
activity level was not available. Also,
some people without known diabetes at
baseline were probably not identiﬁed due
to the absence of a postchallenge glucose
test (23). In Norway it is likely that being
diagnosed with diabetes could vary by
population subgroups that had differen-
tial use of health care services and health
literacy. As in all observational studies,
residual confounding due to unknown
or unmeasured factors cannot be ruled
out. Several of the factors that we adjusted
for could be on the causal pathway be-
tween physical activity and cardiovascu-
lar mortality, such that overadjusting
could have occurred. However, the small
difference between age and multivariably
adjusted estimates suggests that this is not
likely.
Several previous prospective cohorts,
including TheReykjavik Study (6), theNa-
tional Health and Nutrition Examination
Survey 1 study (34), the Framingham
Heart Study (35), and studies from the ﬁrst
HUNT survey (7,11) found a two- to four-
fold higher cardiovascular mortality
among people with diabetes. Our results
showed an approximately twofold in-
crease in risk of death from cardiovascular
disease among peoplewith diabetes, with a
somewhat stronger association among
women than among men. This is in accor-
dance with other studies that reported the
association of diabetes with cardiovascular
mortality to be higher among women
(11,36). Treatment of cardiovascular risk
factors could favor men more than
women, such that women with diabetes
have more adverse cardiovascular risk
proﬁles (36).
Previous studies have also shown that
increasing levels of physical activity are
associated with lower risk of cardiovas-
cular death among people with diabetes
(12,13) and in the general population
(37,38). Comparisons between studies
are difﬁcult due to different methods of
assessing physical activity. Nevertheless,
the most physically active people with di-
abetes have been shown to have approx-
imately half the risk compared with
inactive patients with diabetes (12,13),
similar to our results.
Several possible mechanisms may ex-
plain how physical activity reduces the
risk of cardiovascular death among peo-
ple with diabetes. Recent studies have
reported that regular physical activity
improves glycemic control, insulin sensi-
tivity, blood pressure, lipid proﬁle, and
body composition in people with diabetes
(14–17). Prospective studies have
shown a weak independent association
between hyperglycemia and risk of
Table 3dThe combined effect of diabetes and physical activity on risk of death from cardiovascular disease
Physical activity
No diabetes Diabetes
Person-years Deaths HR (95% CI)a Ptrend
b Person-years Deaths HR (95% CI)a Ptrend
b
N N
Inactive 35,056 215 1.00 (Reference) d 1,102 33 2.81 (1.93–4.07) d
Light activity
,1 h 48,182 153 1.04 (0.84–1.28) d 997 19 2.81 (1.75– 4.51) d
1–2 h 62,459 192 0.86 (0.71–1.05) d 1,438 15 1.07 (0.63– 1.81) d
$3 h 36,220 172 0.78 (0.63–0.96) 0.007 1,055 11 0.89 (0.48– 1.63) ,0.001
Total activityc
Low 200,260 648 0.92 (0.78–1.07) d 2,212 78 1.77 (1.36– 2.30) d
Medium 213,450 507 0.74 (0.63–0.87) d 4,796 38 1.04 (0.73– 1.47) d
High 181,546 184 0.66 (0.53–0.81) ,0.001 2,387 13 0.91 (0.51– 1.60) ,0.001
aAdjusted for age (as the time scale), sex (man, woman), smoking status (never, former, current, unknown), alcohol consumption (0, 1, 2–3,$4 times last month,
total abstainer, unknown), education (,10, 10–12, .13 years, unknown), BMI (kg/m2), systolic blood pressure (mmHg), and total serum cholesterol (mmol/L).
bTest for linear trend across categories of physical activity. cTotal activity level deﬁned as inactive (no light or hard activity, 2), low (,3 h light and/or ,1 h hard
activity), medium ($3 h light and/or ,1 h hard activity), and high (any light and .1 h hard activity).
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cardiovascular disease in people with di-
abetes (7,39). High cholesterol levels in-
crease the risk of cardiovascular disease,
both in people with (14,39) and without
diabetes (13,39,40), as do high blood
pressure and BMI (13). Thus, the protec-
tive effect of physical activity observed in
our study may likely be explained by the
sum of improvements in conventional
cardiovascular disease risk factors. People
with diabetes in the current study who
reported only 1–2 h of light physical ac-
tivity per week had a signiﬁcantly lower
mortality than those who reported no ac-
tivity. If conﬁrmed, this suggests that the
favorable effect of physical activity should
be within reach for most people.
In conclusion, the results from this
prospective cohort study show that in-
active people with diabetes had almost
threefold higher risk of cardiovascular
death compared with those without di-
abetes. The excess risk was reduced with
increasing amount of leisure-time physi-
cal activity. Thus physical activity may,
to a large extent, cancel out the detrimen-
tal effect of diabetes on cardiovascular
death, at least among those healthy
enough to do physical exercise. Further-
more, the results suggest that 1–2 h of
nonvigorous activity may be sufﬁcient to
obtain a favorable effect.
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Diabetes severity and the role of leisure time
physical exercise on cardiovascular mortality: the
Nord-Trøndelag Health study (HUNT), Norway
Børge Moe*, Liv Berit Augestad and Tom IL Nilsen
Abstract
Background: Physical activity has been associated with lower cardiovascular mortality in people with diabetes, but
how diabetes severity influence this association has not been extensively studied.
Methods: We prospectively examined the joint association of diabetes severity, measured as medical treatment
status and disease duration, and physical exercise with cardiovascular mortality. A total of 56,170 people were
followed up for 24 years through the Norwegian Cause of Death Registry. Cox proportional adjusted hazard ratios
(HRs) with 95% confidence intervals (CI) were estimated.
Results: Overall, 7,723 people died from cardiovascular disease during the follow-up. Compared to the reference
group of inactive people without diabetes, people with diabetes who reported no medical treatment had a hazard
ratio (HR) of 1.65 (95% CI: 1.34, 2.03) if they were inactive and a HR of 0.99 (95% CI: 0.68, 1.45) if they reported ≥2.0 hours
physical exercise per week. Among people who received oral hypoglycemic drugs or insulin, the corresponding
comparison gave HRs of 2.46 (95% CI: 2.08-2.92) and 1.58 (95% CI: 1.21, 2.05), respectively.
Conclusions: The data suggest a more favourable effect of exercise in people with diabetes who used medication
than in those who did not, suggesting that physical exercise should be encouraged as a therapeutic measure
additional to medical treatment.
Keywords: Diabetes severity, Leisure time physical exercise, Cardiovascular mortality, Epidemiology
Background
Among people with diabetes, the highest risk of death
from cardiovascular disease is found in those treated
with oral hypoglycemic drugs or insulin [1,2] and in
those with longer duration of diabetes [3-6]. The com-
bination of insulin treatment and longer duration of dia-
betes has been associated with a particular high risk of
death from cardiovascular disease [7]. These findings
imply that diabetes treatment and duration are impor-
tant markers for diabetes severity.
Regular physical activity may improve glycaemic con-
trol, insulin sensitivity, and cardiovascular risk factors
(e.g., blood pressure, lipid profile, and body composition)
in people with diabetes [8-11]. It has been reported that
the most physically active people with diabetes have
approximately half the risk of death from cardiovascular
disease, compared to physically inactive people with dia-
betes, [12,13]. In a recent study, people with diabetes who
reported a moderate to high level of leisure time physical
exercise had the same risk of death from cardiovascular
disease as inactive people without diabetes [14]. However,
if the beneficial effect of leisure time physical exercise on
cardiovascular mortality among people with diabetes is
modified by diabetes severity is not known.
The aim of this prospective follow-up study was therefore
to assess whether diabetes severity, measured as medical
treatment status and disease duration, influence the role of
leisure time physical exercise on cardiovascular mortality.
Methods
Subjects
The HUNT Study is a large population-based health sur-
vey in Nord-Trøndelag County in Norway. Between
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1984 and 1986, all inhabitants aged 20 years or older
(85,100) were invited to participate in the first wave of
the study (HUNT 1) and a total of 77,216 (90.7%) accepted
the invitation, filled in a questionnaire and attended a clin-
ical examination. The participants were given a second
questionnaire at the clinical examination to complete at
home and return in a pre-stamped envelope. All partici-
pants in the HUNT Study gave a written informed consent
upon participation and the study was approved by the
Regional Committee for Ethics in Medical Research.
For the purpose of the present study, a total of 21,046
participants were excluded at baseline; 4,413 who
reported prevalent cardiovascular disease (i.e. angina,
myocardial infarction, and/or stroke), 1,003 without suf-
ficient information on diabetes (diagnosis, treatment or
duration), 15,227 without information on leisure time
physical exercise and 403 without information on poten-
tially confounding factors (i.e. systolic blood pressure,
body mass index). After these exclusions, 56,170 partici-
pants (27,321 men (mean age= 47.4 years old) and
28,852 women (mean age= 48.5 years old)) were avail-
able for follow up on cause of death.
Follow-up
Individual person time at risk of death was calculated
from the date of participation in the HUNT 1 study
(1984–86) until the date of death or until the end of
follow-up 31st December 2008, whichever occurred first.
The mandatory reporting of death to the Cause of Death
Registry in Norway constitutes the basis for the coding
of underlying cause of death. Deaths were classified
according to the International Classification of Disease
(ICD-9 and ICD-10). Cardiovascular disease was defined
by ICD-9: 390–459 and ICD-10: I00-I99, and ischemic
heart disease by ICD-9: 410–414 and ICD-10: 120–125.
Study variables
A detailed description of selection procedures, question-
naires, and measurements can be found at http://www.
ntnu.edu/hunt and in a report by Holmen and colleagues
[15]. Briefly, information was collected on a range of life-
style and health related factors, including medical history,
leisure time physical exercise, smoking status, alcohol con-
sumption and education. Height was measured to the
nearest centimetre and weight to the nearest half kilo-
gram, and body mass index (BMI) was calculated as
weight (kg) divided by the square value of height (m).
Blood pressure was measured two times using a mercury
manometer and the mean of the two measures was used.
Diabetes
Participants who answered ‘Yes’ to the question ‘Do you
have or have you had diabetes?’ in the first question-
naire, were defined as having diabetes (N=1,105).
The second questionnaire included additional questions
to those with known diabetes. People who responded ‘No’
to the questions ‘Do you take tablets for your diabetes?’
and ‘Do you take insulin injections?’ were categorized as
people without medication, while people who responded
‘Yes’ to one of the questions were categorized as people
with medication. We did not have sufficient power in the
statistical analyses to assess the two questions separately.
The question ‘When were you first diagnosed with dia-
betes?’ , provided information on diabetes duration.
Leisure time physical exercise
Information on leisure-time physical exercise was
obtained from the second questionnaire. The partici-
pants were asked ‘How often do you exercise (on the
average)?, By exercise we mean going for walks, skiing,
swimming and working out/sports’ with five mutually
exclusive response options: 0, <1, 1, 2–3, ≥4 times per
week. Those who reported exercising once a week or
more were also asked ‘for how long do you exercise each
time (average)?’ , with four mutually exclusive response
options: <15, 15–30, 31–60, >60 min. Based on the in-
formation of both frequency and duration of exercise we
calculated ‘hours of leisure time physical exercise per
week’. The frequency response option 2–3 times per
week was counted as 2.5 times and ≥4 per week counted
as five times, whereas the duration response options
<15, 15–30, 31–60, >60 min were counted as 10, 25, 45
and 75 min, respectively. For the purpose of the statis-
tical analysis, we categorized this variable into three
groups. This resulted in 22,885 physically inactive partic-
ipants, 24,140 participants performing 0.1-1.9 hours of
leisure time physical exercise per week and 8,040 partici-
pants performing ≥2.0 hours of leisure time physical ex-
ercise per week.
Statistical analyses
A Cox proportional hazard model was used to estimate
adjusted hazard ratios (HRs) of death from cardiovascu-
lar disease and ischemic heart disease associated with
diabetes treatment (with or without oral hypoglycemic
drugs or insulin) and duration, and in a separate ana-
lysis, to assess the combined association of leisure time
physical exercise and diabetes treatment with risk of
death. Precision of the estimated hazard ratios was
assessed by a 95% confidence interval (CI). All estimated
associations were adjusted for possible confounding by
attained age (as the time scale) and birth cohort (five
years strata). In multivariable models we adjusted for
smoking status (never, former, current, unknown), alcohol
consumption (0, 1–4, ≥ 5 times last 14 days, total abstainer,
unknown), education (<10 years, 10–12 years, >13 years,
unknown), body mass index (kg/m2) and systolic blood
pressure (mmHg).
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Analyses of the independent association of diabetes
treatment were stratified by sex, whereas analyses of the
combined association were adjusted for sex in a pooled
sample to increase statistical power. The latter was justi-
fied by likelihood ratio tests of interaction with sex in
the independent analyses of diabetes treatment (P = 0.11)
and in the analyses combining diabetes treatment and lei-
sure time physical exercise (P = 0.37).
Additional to the analyses combining leisure time
physical exercise and diabetes treatment, we conducted
analyses of physical activity stratified by diabetes treatment
and tested for possible statistical interaction between the
two variables in a likelihood ratio test. Moreover, a likeli-
hood ratio test was used to assess whether the results were
modified by age at baseline (< 70 years and ≥ 70 years).
We also conducted three sensitivity analyses; first,
people with probable type 1 diabetes (i.e. who were diag-
nosed with diabetes before 40 years of age and reported
insulin injections); second, we excluded the first five
years of follow up to evaluate possible bias that could
arise if people with the most severe diabetes were unable
to be physically active; third, we excluded people who
reported a moderate or high degree of movement
disability.
Departure from the proportional hazards assumption
was evaluated by Schoenfeld residuals and graphical pro-
cedures (log-log plots). All statistical tests were two-sided,
and all analyses were conducted using Stata for Windows,
version 11.2 (StataCorp LP, Texas 77845, USA).
Results
Baseline characteristics of the study population according
to diabetes severity are presented in Table 1. During a me-
dian follow-up of 23.8 years (1,145,786 person-years), a
total of 17,383 people died. Of these, 7,723 people died
from cardiovascular disease and 3,518 from ischaemic
heart disease. Compared to the 16,633 people who were
excluded due to missing data on central variables, the
56,170 included study participants were similar in age
(mean age, 49.7 versus 49.1 years), but were less likely to
Table 1 Baseline characteristics of the study population
No diabetes Diabetes
Characteristics Without medication* With medication*
Men (n=27,318)
No. of participants 26,815 202 301
Mean age at study entry (SD), years 47.0 (16.7) 65.9 (12.3) 62.2 (17.0)
Mean duration of diabetes (SD), years 6.1 (6.7) 11.9 (10.7)
Mean body mass index (SD), kg/m2 25.2 (3.2) 26.3 (3.7) 26.2 (3.8)
Mean SBP (SD), mmHg 138.7 (19.7) 155.5 (25.1) 151.1 (25.4)
Hours of leisure time physical exercise per week, %
Inactive 42.5 47.0 38.2
0.1-1.9 hours 40.5 33.2 35.9
≥ 2.0 hours 17.0 19.8 25.9
Current smoker, % 35.3 31.7 21.0
Alcohol consumption ≥ 5 times last 14 days, % 8.6 7.9 5.3
Women (n=28,852)
No. of participants 28,250 239 363
Mean age at study entry (SD), years 48.1 (17.0) 67.7 (12.5) 66.7 (13.3)
Mean duration of diabetes (SD), years 5.1 (6.0) 10.5 (8.5)
Mean body mass index (SD), kg/m2 24.9 (4.4) 28.5 (5.1) 28.5 (5.4)
Mean SBP (SD), mmHg 135.1 (24.9) 163.0 (28.0) 160.2 (26.4)
Hours of leisure time physical exercise per week, %
None 40.7 43.5 49.0
0.1-1.9 hours 47.0 43.9 34.2
≥ 2.0 hours 12.3 12.6 16.8
Current smoker, % 31.5 13.8 9.1
Alcohol consumption ≥ 5 times last 14 days, % 3.2 1.0 2.2
Abbreviations: SBP Systolic blood pressure.
*Medication refers to oral hypoglycemic drugs or insulin.
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die from cardiovascular disease (age and sex adjusted HR
0.85, 95% CI: 0.81, 0.88). There was no evidence of depar-
ture from the proportional hazards assumption for any of
the exposure variables under study.
Table 2 presents the independent association between
diabetes treatment, measured as medical treatment sta-
tus and duration, with risk of death from cardiovascular
disease and ischemic heart disease. Compared to people
without diabetes, the adjusted HR for cardiovascular
death was 1.59 (95% CI: 1.29, 1.96) among men with dia-
betes who received no medical treatment, and 2.16 (95%
CI: 1.80, 2.60) for men with diabetes who used medica-
tion. These associations were slightly stronger in women,
although no statistical significant interaction with sex
was observed (P=0.11). The adjusted HR for cardiovascu-
lar death was 1.64 (95% CI: 1.34, 2.00) in diabetic women
without medication and 2.85 (95% CI: 2.43, 3.34) for those
who used medication. Overall, the corresponding analyses
of death from ischaemic heart disease gave slightly stron-
ger associations in both men and women.
In a sensitivity analysis we excluded 113 participants
(39 men and 74 women) with possible type 1 diabetes, but
the results remained largely unchanged. The HRs for
people with diabetes who used medication was 2.23 (95%
CI: 1.83, 2.71) in men and and 2.82 (95% CI: 2.36, 3.37) in
women (data not shown). Moreover, tests of interaction
suggest a possible modifying effect of age (Pinteraction = 0.01
in men and 0.03 in women), with a slightly weaker associ-
ation in the oldest age groups (≥70 years). However, strati-
fied analyses showed that all associations between diabetes
treatment status and mortality remained statistically signifi-
cant in both age groups (data not shown).
The association between diabetes duration and mortality
are also presented in Table 2, displaying the HRs after sub-
dividing each of the medical treatment categories into two
categories of disease duration. Overall, disease duration
was not strongly related to mortality from cardiovascular
disease, although the HRs were generally slightly stronger
in the subgroup of longer duration (i.e. ≥5 years for per-
sons without medical treatment, and ≥10 years for those
Table 2 Hazard ratios (HRs) for death from cardiovascular disease associated with diabetes treatment and disease duration
Death from cardiovascular disease Death from ischaemic heart disease
Mortality No. of person-years No. of deaths HR* HR† (95% CI) No. of deaths HR* HR† (95% CI)
Men
No diabetes 545,005 3,802 1.00 1.00 (reference) 1,980 1.00 1.00 (reference)
Diabetes without medication‡ 2,553 91 1.67 1.59 (1.29-1.96) 49 1.85 1.73 (1.30-2.31)
Diabetes with medication‡ 3,739 120 2.09 2.16 (1.80-2.60) 70 2.47 2.53 (1.99-3.22)
No diabetes 545,005 3,802 1.00 1.00 (reference) 1,980 1.00 1.00 (reference)
Diabetes without medication‡
<5 years 1,354 49 1.59 1.54 (1.16-2.05) 29 2.03 1.91 (1.32-2.77)
≥5 years 1,199 42 1.78 1.66 (1.22-2.26) 20 1.65 1.53 (0.98-2.38)
Diabetes with medication‡
<10 years 1,967 71 2.01 2.01 (1.59-2.55) 42 2.40 2.39 (1.76-3.26)
≥10 years 1,772 49 2.22 2.42 (1.82-3.22) 28 2.57 2.77 (1.90-4.04)
Women
No diabetes 597,934 3,442 1.00 1.00 (reference) 1,297 1.00 1.00 (reference)
Diabetes without medication‡ 3,327 100 1.88 1.64 (1.34-2.00) 41 2.00 1.65 (1.21-2.26)
Diabetes with medication‡ 4,228 168 3.12 2.85 (2.43-3.34) 81 3.78 3.44 (2.73-4.33)
No diabetes 597,934 3,442 1.00 1.00 (reference) 1,297 1.00 1.00 (reference)
Diabetes without medication‡
<5 years 2,087 60 1.75 1.61 (1.25-2.09) 23 1.75 1.55 (1.03-2.35)
≥5 years 1,240 40 2.12 1.67 (1.22-2.29) 18 2.45 1.80 (1.12-2.87)
Diabetes with medication‡
<10 years 2,371 104 3.00 2.74 (2.25-3.35) 45 3.26 2.98 (2.20-4.04)
≥10 years 1,857 64 3.36 3.04 (2.37-3.91) 36 4.71 4.25 (3.03-5.95)
Abbreviations: CI confidence interval, HR hazard ratio.
* Adjusted for age (as the time scale) and birth cohort (5 years strata).
† Adjusted for age (as the time scale) and birth cohort (5 years strata), smoking (never, former, current, unknown), education (<10 years, 10–12 years, >13 years,
unknown), alcohol (0, 1–4, ≥ 5 times last 14 days, total abstainer, unknown), systolic blood pressure, body mass index and hours of leisure time physical exercise
per week (inactive, 0.1-1.9 hours, ≥ 2.0 hours).
‡Medication refers to oral hypoglycemic drugs or insulin.
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with medical treatment). The slightly stronger associations
with longer duration were somewhat more evident in the
analyses of ischemic heart disease.
There was statistical evidence of interaction between
diabetes treatment and hours of leisure time physical
exercise per week (P <0.001), suggesting that the favor-
able effect of physical activity were larger in people with
more severe diabetes. Table 3 shows the combined asso-
ciation of diabetes treatment and hours of leisure time
physical exercise per week with death from cardiovascular
disease and ischemic heart disease, using inactive people
without diabetes as the reference group for all compari-
sons. In people with diabetes who did not use medication,
the adjusted HR for cardiovascular death was 1.65 (95%
CI: 1.34, 2.03) for inactive people and 0.99 (95% CI: 0.68,
1.45) for those who reported ≥ 2.0 hours of leisure time
physical exercise per week. Among people with more
severe diabetes (i.e. those who used medication), the ad-
justed HR for cardiovascular death was 2.46 (95% CI: 2.08,
2.92) in people who were inactive and 1.58 (95% CI: 1.21,
2.05) for those who reported ≥ 2.0 hours of leisure time
physical exercise per week. People with diabetes who
exercised 0.1-1.9 hours per week had approximately simi-
lar HRs as those who were inactive. A similar pattern was
observed for death from ischaemic heart disease, although
the difference in HRs between inactive people and the
most active were somewhat larger.
These combined effects were further explored in analyses
of leisure time physical exercise stratified by diabetes status
and treatment. Compared to being inactive, ≥2.0 hours of
physical activity per week was associated with an adjusted
HR of 0.84 (0.89-0.89) in people without diabetes, a HR
of 0.79 (95% CI: 0.56, 1.11) in people with diabetes who
received no medical treatment, and a HR of 0.49 (95%
CI: 0.56, 1.11) in people with diabetes who were medically
treated (data not shown).
In sensitivity analyses, we excluded the first five years
of follow up, and then also people who reported a mod-
erate or high degree of movement disability. Both ana-
lyses gave largely similar results as those presented
above (data not shown).
Discussion
In this large population based cohort study, less severe
diabetes that was not medically treated was associated
with a 60 per cent increased risk of death from cardio-
vascular disease, whereas more severe diabetes treated
with oral agents or insulin was associated with a two-
fold increased risk in men and a nearly three-fold higher
risk in women. Within each category of treatment status,
disease duration was not strongly associated with mor-
tality. Leisure time physical exercise reduced the risk of
death from cardiovascular disease in both categories of
diabetes severity, but there was evidence of a stronger
association in people with more severe diabetes. Corre-
sponding analyses of death from ischaemic heart disease
gave slightly stronger associations, although the preci-
sion of the estimated associations were lower.
The results of the present study are in agreement with
previous prospective studies, showing that people with
Table 3 Hazard ratios (HRs) for death from cardiovascular disease and ischaemic heart disease associated with
diabetes treatment and leisure time physical exercise
Death from cardiovascular disease Death from ischaemic heart disease
Hours of leisure time physical
exercise per week
No. of person-years No. of deaths HR* HR† (95% CI) No. of deaths HR* HR† (95% CI)
Without diabetes
Inactive 468,436 3,108 1.00 1.00 (reference) 1,391 1.00 1.00 (reference)
0.1-1.9 hours 514,603 2,759 0.78 0.83 (0.79-0.87) 1,256 0.79 0.86 (0.80-0.93)
≥ 2.0 hours 159,901 1,377 0.77 0.84 (0.79-0.89) 630 0.80 0.88 (0.80-0.97)
Diabetes without medication‡
Inactive 2,359 95 1.74 1.65 (1.34-2.03) 48 2.04 1.90 (1.42-2.54)
0.1-1.9 hours 2,514 69 1.45 1.44 (1.13-1.83) 30 1.50 1.48 (1.03-2.13)
≥ 2.0 hours 1,008 27 1.06 0.99 (0.68-1.45) 12 1.08 1.02 (0.58-1.80)
Diabetes with medication‡
Inactive 3,151 140 2.49 2.46 (2.08-2.92) 70 2.91 2.92 (2.29-3.72)
0.1-1.9 hours 3,233 91 2.48 2.64 (2.14-3.25) 57 3.41 3.67 (2.81-4.79)
≥ 2.0 hours 1,583 57 1.49 1.58 (1.21-2.05) 24 1.39 1.49 (0.99-2.23)
Abbreviations: CI confidence interval, HR hazard ratio.
*Adjusted for age (as the time scale) and birth cohort (5 years strata), sex (male, female).
†Adjusted for age (as the time scale) and birth cohort (5 years strata), sex (male, female), smoking (never, former, current, unknown), education (<10 years, 10–12
years, >13 years, unknown), alcohol (0, 1–4, ≥ 5 times last 14 days, total abstainer, unknown), systolic blood pressure, body mass index.
‡Medication refers to oral hypoglycemic drugs or insulin.
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diabetes treated with oral hypoglycemic drugs or insulin
have a higher risk of death from cardiovascular disease
than those without medication [1,2]. Several studies have
reported a positive association between diabetes dur-
ation and cardiovascular mortality [3-7], but we did not
find any strong effect of diabetes duration on cardiovas-
cular mortality when diabetes treatment was taken into
account. Although there was no statistically significant
interaction between sex and diabetes treatment in the
present study, the association between diabetes treat-
ment and cardiovascular mortality was somewhat stron-
ger in women than in men. Previous studies have also
reported a stronger association of diabetes with cardio-
vascular mortality in women than in men [16,17].
Findings from observational studies suggest that people
with diabetes who are physically active have approximately
half the relative risk of death from cardiovascular disease
compared to inactive people with diabetes [12,13], although
different methods for measuring physical activity make
comparisons between studies difficult. The results from the
present study suggest a differential effect of physical exer-
cise on cardiovascular mortality by diabetes severity, show-
ing that the favorable effect of exercise was relatively
stronger in those who reported medical treatment than in
those who did not. The beneficial effect of leisure time
physical exercise on cardiovascular mortality in people with
diabetes may be explained by the sum of improvements in
cardiovascular disease risk factors. These risk factors may
be more prevalent in medically treated diabetes. Studies
have reported increased cardiovascular mortality associated
with hyperglycaemia, hypertension, dyslipidaemia and over-
weight in people with diabetes [13,18-20], whereas regular
physical exercise has been shown to improve the same risk
factors [8-11,21]. Moreover, a recent review suggests that
regular physical exercise could reduce the use of anti-
diabetic drugs in people with type 2 diabetes [22].
The strengths of the present study include the
population-based sample, the prospective design, the large
number of participants, the long follow-up period and the
ascertainment of causes of death through the Cause of
Death Registry at Statistics Norway.
Limitations of the study include the assessment of dia-
betes and leisure time physical exercise with a question-
naire at baseline. The self-reported diagnosis of diabetes
in HUNT 1 was validated in a separate study [23], show-
ing that 96.4% of the self-reported diabetes could be
verified in medical files. Still, unknown diabetes could
have underestimated the association between diabetes
and cardiovascular mortality. It is also possible that the
observed associations between diabetes treatment and
cardiovascular mortality could depend on the type of
diabetes. We had no information on type 1 or type 2
diabetes, but a sensitivity analysis excluding people who
were diagnosed with diabetes before <40 years of age
and who reported to use insulin injection suggest no
large bias of the results. It should also be noted that
diabetes treatment and duration is a rough estimate of
diabetes severity. Unfortunately, we did not have infor-
mation on glycaemic control. Nevertheless, the evidence
of a dose-dependent association across diabetes treat-
ment indicates that our classification is able to capture
some of the variation in severity among people with dia-
betes. The physical activity questionnaire used in this
study has been validated against more objective measures
of fitness and activity, such as VO2max and ActiReg, in a
subsample of young men [24]. The questionnaire was re-
ported to have good repeatability and provide a useful
measure of leisure time physical exercise. It is possible that
the reported exercise volume may be overestimated due to
subjective interpretations. However, if the reported exercise
volume is overestimated, the presented associations be-
tween exercise and mortality is likely to be underestimated.
Also, the effects of exercise may be different in young and
elderly people. In the present study, only information on
frequency and duration was used to classify participants.
We acknowledge that exercise intensity could be of impor-
tance for cardiovascular health, but analyses stratified
according to exercise intensity were not possible due to
limited statistical power. Leisure time physical exercise
was only measured at baseline, and information on prior
changes due to diabetes diagnosis or subsequent changes
throughout the follow-up period was not available. Such
changes in physical activity could both attenuate and
strengthen the estimated association. Also, new cases of
diabetes and more people with diabetes receiving medical
treatment could result in an underestimated association
with mortality. Finally, a substantial proportion of partici-
pants were excluded due to missing information on physical
exercise and possible selection bias cannot be ruled out.
Conclusions
In conclusion, the results from this prospective cohort
study show a positive association between diabetes se-
verity, measured by treatment status, and mortality from
cardiovascular disease and ischemic heart disease. Lei-
sure time physical exercise was associated with reduced
mortality, and this association was especially strong
among people with diabetes who reported medical treat-
ment compared to those who did not. This suggests that
physical exercise should be encouraged as a therapeutic
measure additional to medical treatment.
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Aim/hypothesis Diabetes increases the risk of acute myocardial infarction (AMI), and 
effective means for primary prevention are warranted. We prospectively examined the joint 
association of diabetes and leisure time physical activity, as well as of diabetes and body mass 
index (BMI), on the risk of AMI.  
Methods A total of 55,534 men and women in the Norwegian HUNT Study were followed up 
for first AMI by hospital admission registries and the Cause of Death Registry. Cox 
proportional adjusted hazard ratios (HRs) with 95% confidence intervals (CIs) were 
estimated.  
Results Overall, 1,887 incident AMI occurred during 12.3 years. Compared to inactive people 
without diabetes, inactive people with diabetes had a HR of 2.37 (95% CI: 1.58, 3.57), 
whereas the HR among highly active persons with diabetes was 1.04 (95% CI: 0.62, 1.73). 
Normal weight (BMI 18.5-25 kg/m2) persons with diabetes had a HR of 1.60 (95% CI: 1.05-
2.44) and obese (BMI >30 kg/m2) persons with diabetes had a HR of 2.55 (95% CI: 1.97, 
3.29) compared to normal weight persons without diabetes. The data suggest biological 
interaction between diabetes and physical activity, with a relative excess risk of inactivity and 
diabetes of 1.43 (95% CI: 0.08-2.78). For obesity and diabetes, the excess risk due to 
interaction was smaller (0.67; 95% CI: -0.24-1.58). 
Conclusions/interpretation Body weight, and in particular physical activity, modified the 
association between diabetes and risk of first AMI. This highlights the potential importance of 
physical activity and weight maintenance in primary prevention of AMI among people with 
diabetes. 
Key words Acute myocardial infarction, Diabetes mellitus, Epidemiology, Physical activity  
Abbreviations  
AMI: acute myocardial infarction 
HR: hazard ratio 
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Diabetes induce vascular dysfunction that predisposes to atherosclerosis [1, 2], and is 
associated with about a two-fold increased risk of acute myocardial infarction (AMI) [3-5]. 
Although a broad-based treatment may improve survival in people with diabetes with existing 
cardiovascular disease, the knowledge of effective means for primary prevention of AMI 
among people with diabetes is still sparse [6].  
People with diabetes are recommended to be physically active at least 150 minutes per 
week and to reduce or maintain their body weight [7, 8]. Physical activity can improve 
glycemic control and insulin sensitivity, as well as conventional cardiovascular risk factors 
such as blood pressure and blood lipids [9-12]. Correspondingly, people with a body mass 
index <25 kg/m2 have better glycemic control, insulin sensitivity, blood pressure, and lipid 
profile than their overweight or obese counterparts [13-16]. This may indicate that being 
physically active and being normal weight are two interrelated factors that could counteract 
atherosclerotic processes and reduce the excess risk of AMI seen among people with diabetes.  
The objective of this large population-based cohort study was therefore to 
prospectively examine whether physical activity and body mass index could modify the 
association between diabetes and risk of AMI among people without existing cardiovascular 
disease. 
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METHODS 
Subjects 
The HUNT Study is a large population-based health survey in Nord-Trøndelag County in 
Norway. Between 1995 and 1997, all inhabitants aged 20 years or older (94,194) were invited 
to participate in the second wave of the study (HUNT 2) and a total of 64,961 (70%) accepted 
the invitation, completed questionnaires, and attended a clinical examination. All participants 
in the HUNT Study gave a written informed consent upon participation and the study was 
approved by the Regional Committee for Ethics in Medical Research. 
For the purpose of the present study, a total of 9,427 participants were excluded at 
baseline; 2,443 with prior AMI, 40 without information on diabetes status, 6,357 without 
information on leisure time physical activity, 342 without information on body mass index, 
and 245 without information on potentially confounding factors (i.e. systolic blood pressure 
or total serum cholesterol). After these exclusions, 55,534 participants (26,229 men and 
29,305 women) were available for statistical analyses.  
 
Follow-up 
From the date of participation in the HUNT 2 study (1995-97), the participants were 
followed-up until a diagnosed first AMI or until the end of follow-up 31st December 2008. 
AMIs were primarily identified through medical records from the two hospitals in Nord-
Trøndelag County, but also through a linkage with the National Cause of Death Registry. The 
mandatory reporting of death to the Cause of Death Registry at Statistics Norway constitutes 
the basis for the coding of underlying cause of death. Deaths were classified according to the 
ICD-9 and ICD-10. AMI was defined by ICD-9 code 410 and ICD-10 code I21, when 
identified through the Cause of Death Registry. The diagnosis of myocardial infarction 
followed international recommendations (1st definition of myocardial infarction [17] and 2nd 
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universal definition of myocardial infarction [18]). Central in the diagnosis is the rice and fall 
of cardiac biomarkers above the 99th percentile of detection. Troponin I and T was included in 
the two hospitals from 1998 and from 2001 CK and CK-MB have been excluded from the 
routine diagnostic kit. In addition to the myocardial cell death detected by the biomarkers at 
least one of the following was necessary: Ischemic symptoms (mostly chest discomfort or 
dyspnea)/ changes of the electrocardiogram (ECG) indicative of ischemia (development of 
pathological Q-waves, dynamic ST-segment changes, T-wave inversions or left bundle branch 
block). The cardiac units at the two hospitals validated most of the infarctions, and only 
approximately 5% of the infarctions are validated at departments outside a cardiac unit, i.e. 
internal medicine or surgery. 
 
Study variables 
A detailed description of selection procedures, questionnaires, and measurements can be 
found at http://www.ntnu.edu/hunt and in a report by Holmen and colleagues [19]. Briefly, 
information was collected on a range of lifestyle and health related factors, including medical 
history, physical activity, smoking status, alcohol consumption, and educational attainment. 
At the clinical examination, standard anthropometric measures were obtained in standing 
subjects without shoes (height to the nearest centimetre, weight to the nearest half kilogram, 
and waist and hip circumference to the nearest centimetre). Body mass index was calculated 
as weight (kg) divided by the squared value of height (m). For the purpose of the statistical 
analysis people were defined as normal weight (<25.0 kg/m2), overweight (25-29.9 kg/m2), 
and obese (≥30 kg/m2). In the former group, 2.5 % had a body mass index <18.5 kg/m2, and 
were excluded from the analysis of BMI due to possible bias by pre-existing conditions. 
Blood pressure was measured three times using a Dinamap 845XT (Critikon, Tampa, USA), 
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and the mean of the second and third measure was calculated. A non-fasting whole blood 
sample was drawn from all participants at the screening site. Blood was separated by 
centrifuging before the serum samples were transported in a cooler to the Central Laboratory 
at Levanger Hospital and analysed on a Hitachi 911 Auto-analyzer (Hitachi, Mito, Japan). 
Glucose was measured using an enzymatic hexokinase method and total cholesterol using an 
enzymatic colorimetric cholesterolesterase method. All exposures were measured once, at 
baseline, without any updated information throughout the follow-up period. 
 
Diabetes 
Diabetes status was defined by two methods: First, participants who answered ‘Yes’ to the 
question ‘Do you have or have you had diabetes?’ were defined as having diabetes (N=1,200). 
Persons who answered ‘No’ to the diabetes question above, but who presented with a non-
fasting glucose level ≥11mmol/l at the examination, were classified as having newly 
diagnosed diabetes (N=166). A similar procedure has also been used in previous studies [20-
22]. Ideally, this criterion should be accompanied by information on symptoms of diabetes 
(e.g. polyuria) [22], but this information was not available. Those confirming diabetes in the 
questionnaire were invited to a follow-up investigation. A total of 926 individuals (77 % of 
the invited) took part in these investigations, where blood glucose, serum C-peptide and 
GADA were measured in a fasting state.  In addition, GADA was analyzed in cases declaring 
diabetes but not attending the follow-up and having serum available from a non-fasting state 
(N = 228). Among those attending the follow-up information, those with an anti-GAD level > 
8.0 or an anti-GAD < 8.0 and a C-peptid < 150 pmol/l were classified as having type 1 
diabetes. Among those not attending the follow-up, only the former diagnostic criteria (anti-
GAD level > 8.0) was used to classify diabetes type 1. This resulted in a total of 185 people 
being classified as having type 1 diabetes. 
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Leisure time physical activity 
Information on leisure-time physical activity was obtained from the first questionnaire. 
Participants were asked to report their usual weekly hours of light and/or hard leisure time 
physical activity during the past year, with four response options (0, <1, 1-2, and ≥3 hours) 
for light activity, and the same response options for hard activity. In the questionnaire, light 
activity was defined as ‘not sweating/being out of breath’, whereas hard activity was defined 
as ‘sweating/out of breath’. For the purpose of the statistical analysis, a new variable was 
constructed based on the information on hours of both light and hard activity during a week, 
providing information on total leisure time physical activity level. The participants were 
classified into the following four categories of leisure time physical activity; inactive (no light 
or hard activity), low (<3 hours light and/or <1 hour hard activity), medium (≥3 hours light 
and/or <1 hour hard activity), and high (any light and ≥1 hour hard activity). To increase 
statistical power, those with a low and medium level of physical activity was collapsed into 
one group (‘low/medium’).  
 
Statistical analyses 
A Cox proportional hazard model was used to estimate adjusted hazard ratios (HRs) of first 
AMI associated with diabetes, and in separate analyses, to assess the combined association of 
physical activity and diabetes, and body mass index and diabetes, with the risk of AMI. We 
also combined the information on body mass index and physical activity to examine risk of 
AMI among people with diabetes. Precision of the estimated hazard ratios was assessed by a 
95% confidence interval (CI). All estimated associations were adjusted for possible 
confounding by attained age (as the time scale) and birth cohort (five years strata). In 
multivariable models we adjusted for smoking status (never, former, current, unknown), 
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alcohol consumption (never, not the last 4 weeks, 1-3 units the last 4 weeks, more than 4 units 
the last 4 weeks), education (<10 years, 10-12 years, >13 years, unknown), body mass index 
(kg/m2), systolic blood pressure (mmHg) and total serum cholesterol (mmol/l). Additionally, 
we controlled for leisure time physical activity level (inactive, low, medium, high) when 
estimating the associations between diabetes and risk of AMI. The analyses of the combined 
associations of diabetes and physical activity were conducted sex-specific and in the pooled 
sample adjusting for sex in the regression model. We used a likelihood ratio test of a product 
term in the model to assess statistical interaction (i.e. departure from a multiplicative effect) 
between diabetes and sex, and between diabetes and physical activity. Additionally, the 
association between leisure time physical activity level and risk of AMI was assessed in 
analyses stratified by diabetes status. Finally, in an additive model we estimated the relative 
excess risk due to interaction (RERI) between physical activity and diabetes, as wells as 
between body mass index and diabetes. We used a method described by Anderrson et al. 
2005, to calculate 95% CIs around the RERI estimate[23]. A RERI larger than zero may 
suggest biological interaction between two or more risk factors. 
Departure from the proportional hazards assumption was evaluated by Schoenfeld 
residuals and graphical procedures (log-log plots). All statistical tests were two-sided, and all 
analyses were conducted using Stata for Windows, version 11.2 (StataCorp LP, Texas 77845, 
USA).  
 
RESULTS 
Baseline characteristics of the study population according to diabetes severity are presented in 
Table 1. During a median follow-up of 12.3 years (654,928 person-years), 1,887 persons had 
been diagnosed with a myocardial infarction (1,237 men and 650 women). There was no 
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evidence of departure from the proportional hazards assumption for any of the exposure 
variables under study. Compared to the 7,029 participants who were excluded due to missing 
values on central variables, the 55,534 included in the analyses were on average younger 
(mean age, 47.9 versus 65.0 years) and had a lower risk of death from cardiovascular disease 
(age and sex adjusted HR: 0.79, 95% CI: 0.72, 0.86). 
Table 2 presents the associations of diabetes with the risk of a first AMI among people 
without cardiovascular disease at baseline. Both men and women with diabetes (N = 1,366) 
had a higher risk of myocardial infarction than people without diabetes (Table 2). The 
adjusted HR was 1.49 (95% CI: 1.20, 1.86) in men and 2.76 (95% CI: 2.17, 3.51) in women. 
In a sensitivity analysis we excluded the 164 people with newly diagnosed diabetes based on a 
non-fasting glucose >11.0 mmol/L, but the HRs remained largely similar to those observed 
for the total diabetes group; 1.57 (95% CI: 1.24, 1.98) in men and 2.79 (95% CI: 2.18, 3.57) 
in women (data not shown). There was statistical interaction between diabetes and sex 
(P<0.001), with a stronger association among women than among men. However, the sex 
specific analyses of the combined association of diabetes and physical activity had lower 
statistical power, due to few cases of AMI in some of the categories of physical activity (e.g. 
no women with diabetes and a high level of physical activity). Thus, the main results are 
based on the pooled sample.  
Figure 1a (and Supplementary table 1) shows the combined associations of diabetes 
and leisure time physical activity level on risk of AMI, using inactive people without diabetes 
as the reference group for all comparisons. People with diabetes who were classified as highly 
active (i.e. at least 1 hour of hard activity) had similar risk (HR: 1.04; 95% CI: 0.62, 1.74) as 
the reference group of inactive people without diabetes. The corresponding HR among 
persons without diabetes who were highly active was 0.77 (95% CI: 0.64, 0.94). Leisure time 
physical activity level was inversely and dose-dependently associated with risk of AMI in 
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both people with and without diabetes (Ptrend =0.019 and 0.010, respectively). Supplementary 
table 2 shows the combined association of diabetes and light leisure time physical activity 
(i.e., no sweating/not being out of breath) among people who reported no hard activity per 
week. Compared to the reference group of inactive persons without diabetes, inactive persons 
with diabetes had a HR of 2.37 (95% CI: 1.58, 3.57), whereas people with diabetes who 
reported ≥ 3 hours of light physical activity per week had a HR of 1.50 (95% CI: 0.94, 2.39). 
Correspondingly, the HR among persons without diabetes who also reported ≥ 3 hours of light 
physical activity was 0.78 (95% CI: 0.63, 0.97). Few cases of AMI among people who 
reported only hard activity prevented separate analyses on this variable (e.g. only two cases of 
AMI among people with diabetes who reported ≥3 hours of hard physical activity). 
Sensitivity analyses were we first excluded 185 persons who were likely to have 
diabetes type 1 (Supplementary table 3) and second, excluded the first three years of follow 
up to avoid possible bias by pre-clinical disease (Supplementary table 4) gave largely similar 
results to those presented above. 
Although, there was no statistical evidence of multiplicative interaction between 
diabetes and leisure time physical activity level (P=0.19), the data suggest biological 
interaction between diabetes and physical activity, with a relative excess risk of inactivity and 
diabetes of 1.43 (95% CI: 0.08-2.78). This implies a synergetic effect of diabetes and 
inactivity on risk of AMI. In an attempt to assess the direct effect of leisure time physical 
activity level with the risk of AMI we did a supplementary analysis stratifying on diabetes 
status (Supplementary table 5). In people without diabetes, the HR was 0.83 (95% CI: 0.71, 
0.97) among those with a low/medium physical activity level, and 0.78 (95% CI: 0.64, 0.94), 
among those with a high physical activity level. In people with diabetes the corresponding 
HRs were 0.64 (95% CI: 0.41, 1.00), 0.47 (95% CI: 0.24, 0.91), respectively. The associations 
were similar without stratifying on diabetes. 
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Figure 1b (and Supplementary table 6) presents the joint associations of diabetes and 
body mass index with the risk of first AMI, using normal weight people (18.5-25 kg/m2) 
without diabetes as the reference group for all comparisons. In people without diabetes the 
HRs were 1.12 (95% CI: 1.00, 1.25) for those who were overweight (25-29.9 kg/m2) and 1.28 
(95% CI: 1.11, 1.47) for those who were obese (≥ 30 kg/m2). In people with diabetes, the HRs 
were 1.60 (95% CI: 1.05, 2.44), 2.18 (95% CI: 1.71, 2.77) and 2.55 (95% CI: 1.97, 3.29) for 
those who were normal weight, overweight and obese, respectively. The relative excess risk 
for AMI due to interaction between diabetes and obesity was 0.67 (95% CI: -0.24-1.58). 
When treating BMI as continuous variable in the model, one unit increase in BMI was 
associated with a HR of 1.01 (95% CI: 1.02,1.04) among people with diabetes and a HR of 
1.02 (95% CI: 1.01, 1.04) in those without diabetes. 
In Table 3 we combined the information on body mass index and leisure time physical 
activity level to examine risk of AMI among people with diabetes. Compared to the reference 
group of participants with a body mass index ≥25 kg/m2 and an inactive/low level of physical 
activity, people with a medium/high level of activity and a body mass index ≥25 kg/m2 had a 
HR of 0.90 (95% CI: 0.64, 1.26). Among people with a body mass index between 18.5-25 
kg/m2, the HRs were 0.89 (95% CI: 0.48, 1.64) among those who had an inactive/low level of 
physical activity, and 0.51 (95% CI: 0.26, 0.99) among those with a medium/high level of 
physical activity. 
 
DISCUSSION 
In this large population based cohort study, diabetes was associated with an increased risk of 
first AMI, with a stronger association among women than men. The adverse association of 
diabetes on risk of AMI were modified by both leisure time physical activity and body mass 
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index. Diabetes was associated with more than two-fold increased risk among those who 
reported being physically inactive, whereas those reporting a high physical activity level had 
largely similar risk as inactive people without diabetes. Also among obese people, diabetes 
was associated with a more than two-fold increased risk of AMI, whereas this risk was 
substantially lower among normal weighted people. Among people with diabetes, the most 
physically active and with normal weight had half the risk of those who were least physically 
active and overweight or obese.   
 To our knowledge, the present study is the first study to show that physical activity 
and body mass index modifies the association between diabetes and risk of AMI among 
people without existing cardiovascular disease. Similar to the present study, previous studies 
have showed that diabetes increase the risk of AMI [3-5] with a stronger association among 
women than men [4, 5], and that the most physically active people with diabetes have 
approximately half the risk of cardiovascular death compared to inactive people with diabetes 
[24, 25].  Moreover, we have recently shown that physical activity modified the association 
between diabetes and mortality[26]. Also, people with diabetes and a low body mass index 
have been reported to have lower risk of death from cardiovascular disease, than obese people 
with diabetes [27]. The Look AHEAD Research Group recently reported that an intensive 
lifestyle intervention that promoted weight loss through caloric intake and increased physical 
activity did not reduce the rate of cardiovascular events in overweight or obese people with 
type 2 diabetes [28]. However, a large observational study found that increased physical 
activity during a five year period was associated with a considerably lower risk of 
cardiovascular disease than people who remained at a low physical activity level [29].  
 The strengths of the present study include the population-based sample, the 
prospective design, and the large number of participants. Additionally, the ascertainment of 
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first AMI, either identified through medical records, or through the National Cause of Death 
Registry allows for a complete measure of outcome and practically no dropouts throughout 
the 12-year follow-up period. Improved survival from cardiovascular disease due to improved 
treatment suggests that using first AMI may be a more appropriate endpoint than mortality, 
which is more commonly used. The large number of potential confounding factors is another 
important strength, although residual confounding due to unknown or unmeasured factors 
cannot be ruled out. 
 Limitations of the study include the classification of diabetes and leisure time physical 
activity by self-report at baseline, and without follow-up information. The self-reported 
diagnosis of diabetes in HUNT 1 was validated in a separate study [23], showing that 96.4 % 
of the self-reported diabetes could be verified in medical files. We are not aware of studies 
that have evaluated the reliability of using a non-fasting glucose level ≥11mmol/l as a cut-off 
for diabetes, although a similar procedure has been used in previous studies [20-22] People 
being diagnosed with diabetes during the follow-up could have underestimated the 
associations between diabetes and myocardial infarction. We did not have data on 
cardiorespiratory fitness, which have been suggested as a more important predictor for 
cardiovascular outcomes than both physical activity [30] and obesity [31]. Nevertheless, 
regularly performed physical activity have been shown to improve physical fitness in people 
with type 2 diabetes [32], suggesting that self-reported physical activity, at least to some 
degree, may reflect the participants physical fitness. The question about hard activity in the 
present study have been found to correlate well with VO2max in a subsample of young men, 
while light activity showed no correlation [33]. Although light activity did not correlate with 
VO2max, it may elicit other biological mechanisms that are beneficial for cardiovascular health 
(e.g. improved glycaemic control) [33].  A recent study which objectively assessed 
14 
 
ambulatory activity found that both baseline levels and changes in ambulatory activity 
displayed a graded inverse association with subsequent risk of cardiovascular events [34]. It 
has also been reported that the most prevalent leisure time behaviour, television viewing, is 
associated with increased risk of cardiovascular disease, independently of total level of 
physical activity [35]. These studies suggest that light intensity physical activity and reduced 
sedentary behaviour may have beneficial effects without improved cardiorespiratory fitness. 
Also, because the questions did not distinguish between resistance and endurance training, 
differences associated with the two types of activity could not be estimated. Subjective 
interpretation of the activity questions could have influenced the results. If the interpretation 
of activity is related to diabetes status this could have over- or underestimated our results. On 
the other hand, if the interpretation of activity is unrelated to diabetes status, the associations 
would be attenuated towards the null. Individual changes in physical activity during the 
follow-up could both attenuate and strengthen the estimated association. Another possible 
limitation to the results of this and nearly every similar study is the possibility for collider  
bias [36]. Diabetes, or survival until onset could be a collider (caused by two factors, e.g., 
physical activity and some other risk factor) so that stratification may induce an association 
between physical activity and another risk factor, potentially biasing the association of 
physical activity with the outcome [37]. Although it is possible that some people could have 
been hospitalized in another county (e.g. people living near the county border), and thus not 
registered with AMI in our data, this misclassification is not likely to be differential between 
people with and without diabetes. 
There are several possible interrelated mechanisms that may explain how physical 
activity and maintaining a normal body weight could reduce risk of first AMI among people 
with diabetes. Physical activity may improve cardiovascular risk factors (e.g., blood pressure, 
lipid profile, and body composition) [9-12], and people with a normal body mass index have 
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better glycemic control, insulin sensitivity, blood pressure and lipid profile than their obese 
counterparts [13-16]. Thus, it is likely that the beneficial effects of physical activity and 
maintaining a normal bodyweight are explained by the sum of improvements in 
cardiovascular risk factors. 
 In conclusion, the results from this prospective cohort study showed that inactive 
people with diabetes had a more than two-fold increased risk of a first AMI, compared to 
inactive people without diabetes. This excess risk was cancelled out among people with 
diabetes who reported a high physical activity level. Moreover, a normal body weight was 
also associated with lower risk of first AMI, especially when combined with a moderate or 
high level of physical activity. The data suggest that leisure time physical activity and weight 
maintenance may be effective means for the primary prevention of acute myocardial 
infarction among people with diabetes. 
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